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Abstract 
Soils are home to a remarkable array of biodiversity with some estimates stating that 25% of the 
Earth’s species find their home in the soil. Of these organisms, the vast majority are not of any threat 
to human health, but rather function to provide numerous ecosystem services which emerge through 
the multitude of complex interactions between organisms within the soil and the soil itself. These 
ecosystem services range from those which are vital for maintaining life on Earth, such as the 
formation of soil, the cycling of nutrients with the result of maintaining soil fertility, and the filtering 
of water, as well as provision of useful compounds such as antibiotics, the majority of which have 
been isolated from soil organisms.  
However, soils also contain microorganisms which are capable of causing diseases in humans. They 
act either as opportunistic pathogens which take advantage of susceptible individuals, such as those 
who are immuno-compromised; or as obligate pathogens which must infect humans in order to 
complete their life-cycles. These organisms may be capable of surviving within the soil for extended 
periods of time before infecting humans who come into contact with contaminated soil. 
This report provides an overview of the various soil borne diseases which can affect humans, including 
a discussion of the literature where available for each disease, and an analysis of the evidence for why 
each disease may be considered to be soil borne. Information from the World Health Organisation 
(WHO) and the European Centre for disease prevention and control (ECDC) on infection and mortality 
rates within the EU27 is also presented. However, limitations with the data sets prevent accurate 
qualitative analysis such as which diseases have the highest recovery rates in which member state, 
numbers of non-lethal disease cases, etc. A discussion of the factors which may affect the incidence of 
such diseases; including land management practices or land use change, climate change, and the use of 
antibiotics in livestock, is presented. Finally, areas of future research which are needed are highlighted 
to aid further investigation of this important and yet understudied area. 
 
 
1. Introduction 
Before progressing any further with this report it is vital to state that while the diseases discussed in the 
following pages are caused by organisms which inhabit the soil, these organisms form by far and away 
the minority of soil organisms in the vast majority of situations, both in terms of abundance and 
species richness. Soils are arguably the most complex systems on the planet, when comparing the scale 
of heterogeneity in both time and space with other ecosystems. They are home to a remarkable array of 
biodiversity with some estimates stating that 25% of the Earth’s species find their home in the soil. Of 
these organisms, the vast majority are not of any threat to human health, but rather function to provide 
numerous ecosystem services which emerge through the multitude of complex interactions between 
organisms within the soil and the soil itself. These ecosystem services range from those which are vital 
for maintaining life on Earth, such as the formation of soil, the cycling of nutrient with the result of 
maintaining soil fertility, and filtering of water (MEA 2005), as well as provision of useful compounds 
such as antibiotics, the majority of which have been isolated from soil organisms (Turbé et al. 2010).  
The fact that many antibiotics have been isolated from soil organisms is due to the competitive nature 
of life within the soil. Soils, particularly at the micro-scale at which most soil organisms exist, consist 
of finite or even sparse resources in the form of water, food and space. It is because of this competitive 
existence, with organisms striving to utilise resources often while fighting off the advances of 
organisms with which they are competing, that some organisms engage in a form of chemical warfare 
by excreting compounds that can kill or interfere with the growth of other nearby microorganisms 
which come into contact with these compounds. Humans have isolated and utilise many of these 
compounds as antibiotics which aid in the fight against human disease. However, these adaptations in 
some soil organisms which may help survival in the soil can sometime be turned against humans if 
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these organisms infect susceptible individuals, and so can become the causative agents of soil borne 
diseases in humans.  
This risk of exposure to infectious organisms from the soil has been known for centuries. For example, 
Hippocrates, in 4th century BC, stated that is necessary to beware of “…the soil too, whether bare and 
dry or wooded and watered, hollow and hot or high and cold”. It is clear that infection from soil is by 
no means a new phenomenon although our understanding of mechanisms has obviously increased 
greatly since the time of Hippocrates. Owing to vaccines and antibiotics we have been slowly wining 
the battle against disease over the last few decades, but with the rise of antibiotic resistance in some 
pathogens it is clear that prevention is better than the cure. So, which diseases are soil borne? Is there 
anything that we can do with regard to land management practices or other precautions that we can 
take which will help control the incidence of soil borne diseases? And are there any human activities 
that enhance the risk of soil borne diseases? 
 
1.1 Aims of this report  
This report aims to be a first step towards bringing information together from various sources into one 
easily accessible source of information on soil borne diseases, covering all groups of pathogenic 
organisms of humans that are associated with the soil. 
The first step is to identify which diseases are soil borne. Each of these diseases will then be discussed 
in turn, providing a brief overview of the disease, its cause, progression in humans and general 
prognosis. Research will be pulled together to discuss how each organism is associated with the soil, 
where available, which will then be critically analysed to identify areas of further research. Data 
available publically from the World Health Organisation (WHO) and European Centre for Disease 
Prevention and Control (ECDC) on infection rates and mortalities will be presented where available 
and discussed. 
Finally, a literature review of anthropogenic activities which may affect soil borne pathogenic 
organisms and the incidence of diseases associated with such organisms will be performed, and 
recommendations made for the next steps towards achieving a full understanding of soil borne 
pathogenic organisms, their role in the environment, their impact on human health within Europe, and 
any steps that may be possible to limit or reduce the number of soil borne diseases in humans. For 
example, the misuse of soil by humans which can lead to soil degradation processes might also 
enhance soil borne disease incidence, for example through increasing wind erosion and so the amount 
of airborne spores from the soil. This report will attempt to identify whether or not such factors may 
play a role in the incidence of human disease from the soil 
 
1.2 Estimates of number of infections and mortalities 
All data quoted in this report for infection rates were obtained from The European Centre for Disease 
Prevention and Control (ECDC) who compile data obtained through The European Surveillance 
System (TESSy), whereby member states are required to track and report data concerning rates of 
infection of communicable diseases as described in Decision No2119/98/EC. Of those communicable 
diseases which are tracked, 18 have been identified as soil borne diseases within the confines of this 
report, and the data which is available (from 2006-2009) are discussed in this report. 
Data on mortality rates are logged with the WHO that collates data from death certificates for 
approximately 100 member states of the WHO. Data were extracted from this database for mortalities 
attributed to the soil borne diseases identified in this report for each of the 27 EU member states where 
available on the ICD10 codes. The ICD10th revision was adopted by the World Health Assembly in 
1990. It came into effect as from 1993 with the number of countries submitting their underlying causes 
of death data using ICD10th revision to WHO increasing from 4 countries in 1995 to 75 in 2003 and to 
over 100 in 2007. This means that data is not always available for the same timeframe in each country 
concerning each disease.  
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1.3 Soil borne human diseases 
So, what are soil borne human diseases in the context of this report? Many infectious diseases may be 
considered to be soil borne to some extent. However, many of those would likely require quite 
contrived situations which, while theoretically possible, are seemingly unlikely. An example of such a 
disease is measles. This is a highly infectious viral disease. While it can theoretically be transmitted 
through soil, the virus is known to survive only very poorly in the air and on surfaces (approximately a 
30 – 70% reduction in the number of viable virus particles in the first minute of leaving the body 
depending on the relative humidity of the air). Therefore, the risk of transmission through air, and 
particularly from other surfaces such as the soil, is relatively low to minimal, particularly if the 
infected individual is no longer present.  
To include all of the diseases which may be transmitted through the soil in cases where more or less 
immediate exposure after contamination is required for infection to occur would mean the inclusion of 
the majority of transmissible diseases. This carries the risk of obscuring those diseases which truly are 
soil borne, i.e. those diseases which make their home in soil but which are capable of causing disease 
in humans, or those diseases that can survive for a sufficient time in the soil that the original infected 
human can be long departed before the organism infects another human host. With such diseases it can 
be hypothesised that environmental factors such as land management practices, may have an influence 
on the incidence of these diseases and as such it may be possible to find land management practices 
which positively impact on human health. 
Therefore, soil borne human diseases, within the context of this report are defined as being: 
 
“A human diseases resulting from any pathogen or parasite, transmission of which can occur from the 
soil, even in the absence of other infectious individuals” 
 
1.3.1 Euedaphic versus soil transmitted pathogens and parasites 
Table 1 (below) lists all of the human diseases so far identified which fall under the definition of being 
soil borne diseases. The pathogens responsible for causing such diseases can be divided into two 
groups: Euedaphic pathogenic organisms (EPOs), being potential pathogens which are true soil 
organisms, i.e. their usual habitat is the soil. This list includes most of the bacterial pathogens and all 
of the fungal pathogens. The other group consists of soil transmitted pathogens (STPs). These are 
organisms which, while they may be able to survive in soil for extended periods of time, are not true 
soil organisms, but rather are obligate pathogens who must infect a host in order to complete their life 
cycles. It should be noted that as with many classifications and groupings made, strict categorisation 
has it limitations, as rather a continuum is likely to exist with some overlap of organisms between the 
two groupings (for example, strongyloidiasis and shigellosis). This is an initial attempt at defining 
these organisms which may have to be revised as future works is conducted (Table 1).  
 9
Table 1: Soil borne infectious diseases (bold) and their causative agents (italics) split into two 
groups, “Euedaphic pathogenic organisms (EPOs)” and “Soil Transmitted Pathogens (STPs)”, 
depending on the closeness of their relationship with soil. 
Euedaphic pathogenic 
organisms 
Soil Transmitted Pathogens 
Actinomycetoma: (e.g. Actinomyces 
israelii) 
Poliovirus 
Anthrax: Bacillus anthracis Hantavirus  
Botulism: Clostridium botulinium  Q Fever: Coxiella burnetii  
Campylobacteriosis: e.g. 
Campylobacter jejuni  
Lyme disease: Borrelia sp. 
Leptospirosis: e.g. Leptospira 
interrogans  
Ascariasis: Ascaris lumbricoides  
Listeriosis: Listeria monocytogenes Hookworm: e.g. Ancylostoma duodenale  
Tetanus: Clostridium tetani  Enterobiasis (Pinworm) 
Tularemia: Francisella tularensis  Strongyloidiasis: e.g. Strongyloides 
stercoralis  
Gas Gangrene: Clostridium perferingens Trichuriasis (Whipworm): Trichuris 
trichiura 
Yersiniosis: Yersinia enterocolitica  Echinococcosis: e.g. Echinococcus 
multicularis  
Aspergillosis: Aspergillus sp. Trichinellosis: Trichinella spiralis 
Blastomycosis: e.g. Blastomyces 
dermatitidis 
Amoebiasis: Entamoeba histolytica  
Coccidioidomycosis: e.g. Coccidiodes 
immitis  
Balantidiasis  Balantidium coli 
Histoplasmosis: Histoplasma 
capsulatum 
Cryptosporidiosis: e.g Cryptosporidium 
parvum  
Sporotrichosis: Sporothrix schenckii Cyclosporiasis: Cyclospora cayetanensis  
Mucormycosis:  e.g. Rhizopus sp. Giardiasis: Giardia lambila  
Mycetoma:  e.g Nocardia sp. Isosporiasis: Isospora belli 
Strongyloidiasis: e.g. Strongyloides 
stercoralis 
Toxoplasmosis: Toxoplasma gondii  
 Shigellosis: e.g. Shigella dyseneriae 
 Pseudomonas aeruginosa 
 Eschericia coli  
 Salmonellosis: e.g. Salmonella enterica 
 
Once this division is made it can be used to highlight areas of further research and analysis. For 
example, when analysing infection rates it is highly probable that infection with EPOs have occurred 
from the soil, but with STPs it is much less certain; salmonellosis can be contracted as a result of poor 
hygiene by an infected individual who is preparing food. 
Another utility in this distinction is that it is probable that EPOs provide ecosystem services within the 
soil, such as breaking down organic matter, or affecting soil erodibility as in the case of some fungi for 
example. While it is possible that their role is minimal if the pathogens are only present at low 
abundances (as would be expected to be the case for STPs but may not necessarily be the case for 
EPOs which cause diseases opportunistically), in areas which have low species richness the effects of 
some species on their local environment can be disproportionate to their abundance.  
For example, many of the potential diseases causing fungi are hyphal (or dimorphic) and these fungal 
types have been shown to play an important role in stabilising the soil surface. In deserts environments 
with low species richness, the removal of the potential disease causing fungus from the soil may have 
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an impact on the soil surface stability and hence increased effects of wind erosion and decreased water 
holding capacity etc.  
Conversely, it is likely that STPs will provide fewer ecosystem services when in the soil as it is not 
necessarily their “usual” habitat. However, while STPs may not provide ecosystem services while in 
the soil environment, they may well provide ecosystem functions. Soil foodwebs are generally very 
complicated, with several trophic levels and a high level of interconnectedness. While in the soil 
environment, STPs may well provide a food source for other organisms and so their presence may 
have other effects, for example by maybe temporarily allowing an increase in the level of diversity 
through being a novel food source. However, owing to the relatively low levels of abundance of these 
species in the soil any effects are likely to be highly localised. 
While we acknowledge that these differences are currently hypothetical this distinction may also help 
guide policy in the future as well as highlighting the need for research in this area. For example, if it 
can be shown the land or agricultural practices may reduce the abundance of STPs within the soil, or 
the length of time that they remain viable infectious organisms, then implementation of such practices 
may have positive impacts on human health. However, due to the fact the EPOs may provide 
ecosystem services, reducing their abundance further in the soil may have negative effects and enhance 
soil degradation processes.  
 
1.4 Other non-infectious soil associated diseases 
Other diseases which can be obtained from the soil or are associated with the soil include silicosis and 
geophagia which is associated with pica (defined as being a persistent ingestion of eating non-food 
materials) neither of which is caused by an infectious agent. 
 
1.4.1 Silicosis 
Silicosis is generally considered an occupational lung disease as it is most commonly contracted as a 
result of work or occupational activity. It is caused by the inhalation of silica dust and is most common 
in miners and quarry workers but can also affect agricultural workers.  
Symptoms of silicosis include shortness or breath, a cough, inflammation of the lungs, pain while 
breathing and possibly a fever. It is an irreversible condition which has no cure and which continues to 
worsen even after exposure has ended owing to the body’s inability to remove the silica particles from 
the lungs.  
Silicosis is not contagious as there is no biological component and as such is not discussed in detail in 
this report. However, land management practices that reduce wind erosion, which has a possibility of 
lifting silica particles from the soil into the air where they may be inhaled, are likely to have twin 
benefits of reducing soil erosion and concurrently reducing the incidence of silicosis. 
 
1.4.2 Geophagia (pica associations) 
There is a history of geophagia (eating soil) in various areas throughout the world, from a range of 
cultures, and has been documented in many different species including mammals, birds and reptiles 
(Diamond 1999).  
Apart from its obvious role as a potential source of inoculation, geophagia has been recorded as a form 
of pica. However, pica is not a communicable disease and is not transmitted through the soil. 
Therefore it does not fall within the scope of this report and so is discussed no further here. 
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2. Discussion of Soil Borne Diseases 
The following section provides a discussion of the various soil borne diseases, split up into polygenetic 
taxonomic groups for ease of reference. Infectious organisms capable of causing disease come from 
five major phylogenetic groups being viruses, bacteria, protozoa, fungi and helminths (nematodes). 
The final group, helminths, is the only group for which a specific focal point currently exists within the 
WHO for soil transmitted pathogens or parasites, that of “soil transmitted helminths”; currently no 
focal point exists for soil borne infections caused by any of the other four main groups of infectious 
organisms. 
Graphical representations of infection rates by country are included using data available from TESSy 
for those diseases for which data is available within the EU27. Where data were not available for a 
member state for a given disease, this has been mentioned in the figure caption. Several of the diseases 
identified in this report are not tracked by TESSy, including all of the fungal diseases discussed, and as 
such no graph is provided showing infection rates for these diseases. 
 
2.1 Viruses 
Viruses are highly host specific and are incapable of multiplying outside of host cells. Therefore, 
human viruses almost certainly have no functional role within the soil system. This means that they 
can all be considered to be soil transmitted pathogens, as defined by this report (Section 1.4.1), as 
opposed to euedaphic pathogens. 
Some viruses are capable of surviving within the soil system for extended periods of time and to be 
able to adsorb to soil particles and so resist elution (e.g. poliovirus). Others adsorb less strongly to the 
soil and so can become mobilised after rainfall and either washed deeper into the soil profile or to 
different areas depending on the soil hydrology (e.g. other enteroviruses) (Landry et al. 1979). Factors 
which most affect the survival of human pathogenic viruses in the soil are pH level, moisture content, 
temperature, exposure to sunlight and the presence of soil organic matter (WHO 1979). 
 
2.1.1 Enteroviruses 
Human enteric viruses (also known as enteroviruses) are a genus of picornaviruses that include 
polioviruses, coxsackieviruses and echoviruses. They generally infect the gastrointestinal tract of 
humans but may also spread and infect tissues in other areas of the body, particularly the nervous 
system. They have been found to be able to survive for extended periods in some soil environments 
with survival times of up to 170 days reported for virus particles in loamy and sandy loamy soils 
(WHO 1979). Enteric viruses have been recovered at considerable distances from their source owing 
to their generally relatively poor binding to soil particles and soil organic matter meaning that they are 
easily eluted and carried in rainwater. The exception to this is poliovirus which seems to adsorb 
relatively strongly to soil particles (Landry et al. 1979).  
 
Polioviruses are a specific group of enteroviruses. They have been shown to be able to survive within 
the soil environment for between 80 days (Duboise et al 1976) and 96 days (WHO 1979). While these 
viruses seem to adsorb readily to both biological and non-biological surfaces within the soil system, it 
has been demonstrated that this adsorption does not inactive the virus particles (Carlson et al. 1968) 
and so they remain infectious. 
No infections were reported by the ECDC for the years 2006-2008 although 1 infection was reported 
in Poland in 2009. The WHO has 6 deaths registered as being attributed to acute poliomyelitis under 
the ICD10 codes in the EU 27 between 1994 and 2008, although of these only Bulgaria has reported 
any deaths attributed to acute poliomyelitis since 1996 (1 in 2006 and 2 in 2008). 
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2.1.2 Hantavirus 
Hantaviruses are generally considered to be zoonotic, being carried by wild rodents. Infection in 
humans generally occurs either from rodent bites or through coming into contact with infected rodent 
excreta which may be in the soil.  
Hantavirus infection in humans can cause either “hantavirus pulmonary syndrome” (HPS) or 
“hemorrhagic fever with renal syndrome” (HFRS) (Jonsson et al. 2010). The first outbreak of HFRS 
occurred during the Korean War and so HFRS was initially called Korean hemorrhagic fever. HFRS is 
the less fatal form of hantavirus infection with mortality rates in the region of 12% as compared to a 
60% mortality rate with HPS (Jonsson et al. 2010). 
Symptoms are initially flu-like and occur two to three weeks after exposure to the virus. As the 
diseases progresses symptoms usually develop into coughing and difficulty breathing which may be 
accompanied by feeling dizzy, headaches and stomach pain and diarrhea and/ or vomiting (Dugdale et 
al. 2011). 
While HPS and HFRS can be fatal in humans, and may even become life threatening within only a few 
days of early symptoms, the earlier the infection is treated the better as the chances for recovery. The 
virus spreads among the rodent population either through direct contact between infected and non-
infected individuals, or through non infected individuals coming into contact with infected rodent 
excreta in the soil. Humans generally become infected through inhalation of aerosolised viral particles 
(Wesley et al. 2010). This may occur through land management practices such as tillage which 
disturbs the soil and may eject virus particles from the soil into the air, although further research is 
required to investigate how much effect this mechanism and others have on the incidence of the 
disease.  
In 2006, 15 cases of hantavirus infection were reported in Estonia, the only country for which data 
were reported in that year. Seven cases were reported in Estonia in 2007, with Germany and The 
Netherlands reporting 0 cases that year and no other countries within the EU27 providing data. Finland 
reported the highest rate of infection for the two years that data is available (2008 & 2009). In 2008 a 
total of 4479 cases of hantavirus infection were reported within the EU27, with all countries with the 
exception of Cyprus, the Czech Republic, Denmark, France and Portugal providing data to the ECDC. 
In 2009 a total of 2438 cases of hantavirus infection were reported, with the Czech republic providing 
data in 2009, but no data being provided by Cyprus, Denmark, France or Portugal. 
The WHO reported 27 deaths within the EU27 between 1996 and 2008 as attributed to “haemorrhagic 
fever with renal syndrome” which included epidemic Korean, Russian, Hantan virus disease and 
Hantanvirus disease with renal manifestations under the ICD10 codes. Information concerning mean 
annual infection rates per country can be seen in Fig 1. 
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Fig 1: Mean annual infection rates of Hantavirus infection in the EU27 by member state per 
100,000 people for 2006 - 2009. Bars show standard error of between year data. Data not 
available for Cyprus, Denmark, France, Italy or Portugal. 
 
 
2.1.3 Other viruses 
Many other human viruses have either been shown or are thought to only survive relatively poorly in 
the soil system although studies on many viruses are still currently lacking. However, the rubella virus, 
mumps virus, rhinovirus and parainfluenza virus among others, have all been found to survive in the 
external environment, including in the soil, for only a matter of hours and occasionally for a day or two 
(Walther and Ewald 2004). For this reason these diseases are not considered within the scope of this 
report and so are not discussed further. 
 
 
2.2 Bacteria 
The bacteria are a remarkably diverse group of organisms. They form one of the three domains of life, 
along with Archea and Eukaryota, used in modern taxonomy. Bacteria exist at relatively high levels of 
abundance in all ecosystems on the planet that have so far been studied and they play a vital role in 
global functioning through the ecosystem services and functions that they provide. However, there are 
several groups of bacteria which are pathogenic in humans. These include obligate pathogens, and 
opportunistic pathogens which can be divided into different groups. For example, enteric bacteria are 
rod shaped, gram negative bacteria which occur most commonly in the intestines of humans and other 
animals where they may cause disease, mainly diarrhea, in some instances. They include bacteria from 
the genera Campylobacter, E. coli and Shigella sp. which are discussed in more detail below. 
Worldwide, enteric bacteria are estimated to causes between 4 and 6 million deaths each year and are 
the second most common cause of infant mortality globally. Other groups of bacteria, such as the 
actinomycetes, are found more commonly in the external environment but there are some species 
which may be capable of causing disease in humans. A full discussion of the main soil borne 
pathogenic groups follows: 
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2.2.1 Actinomycosis 
Actinomycosis is caused by infectious actinomycete species, often Actinomyces israelii, a soil 
dwelling species that is found in decaying organic matter (Roque 2010). Actinomycetes are generally 
soil inhabiting saprophytes although some species are capable of causing diseases in plants, animals or 
humans. They are generally anaerobic or facultative anaerobic organisms, with some genera such as 
Frankia forming symbiotic relationships with the roots of non-leguminous plants including trees. Here 
they play an important role in maintaining soil fertility due to their ability to fix nitrogen.  
As well as inhabiting the soil, many species of actinomycete can also be found colonising the gut, 
mouth and vagina of humans although the majority of these do not cause diseases.  
Actinomycosis usually presents as a chronic infection that commonly affects the face and neck and can 
include the formation of abscesses in the lungs, intestine or mouth cause by the infection of tissues, 
normally in conjunction with other bacterial species. The disease is only very rarely fatal with only 4 
mortalities recorded in the WHO mortalities database under the ICD 10 codes (2 in Denmark in 1996 
and 2 in Hungary in 2002; WHO 2011). Data on actinomycosis infection rates is not collected by the 
ESDC and so no information is currently readily available on actinomycosis infection rates within the 
EU27. 
 
2.2.2 Anthrax 
Anthrax is a zoonotic disease caused by bacteria of the species Bacillus anthracis, which are gram 
positive, rod shaped, aerobic, spore forming bacteria. The disease is a problem in many countries 
world-wide where it can affect livestock and wildlife. Infections in humans are more usually 
secondary, i.e. passed on to humans by infected animals (Blackburn et al. 2007).  Animals generally 
get anthrax from grazing on soils which contain spores of the bacterium B. anthracis. Humans then 
may become infected through touching infected animals or animal products where the bacterial spores 
may enter into wounds if present, or be inhaled as is the case for “wool sorter’s diseases”; an often 
fatal infection resulting from the handling of infected wool (Van Ness 1971). Anecdotal evidence 
exists that soil management practices such as tillage may increase the risk of human infection of 
anthrax due to inhalation of spores, although there is a paucity of empirical evidence in this regard and 
further research is required to assess the effects of land management practices on the incidence of this 
disease in humans. 
When in spore form, there bacteria are highly resistant to desiccation and other environmental stresses 
and can remain in this inactive form in soil for many years, only becoming active once environmental 
conditions become favourable again. 
The ECDC has between 3 and 14 infections recorded annually attributed to anthrax within the EU27 
between 2006 and 2009 with the highest mean infection rate being in Bulgaria. The WHO mortality 
database has 5 deaths registered as attributed to anthrax septicaemia under the ICD10 codes within the 
EU27, between 2001 and 2004, 4 in Romania, and 1 in the United Kingdom. No deaths were attributed 
to anthrax under the ICD 10 codes in Bulgaria despite having the highest infection rates. Whether this 
is the result of the disease being cured more readily there, or due to deaths being attributed to other 
factors cannot be known from the data which is currently available. Information concerning mean 
annual infection rates per country can be seen in Fig 2. 
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Fig 2: Mean annual infection rates of anthrax in the EU27 by member state per 100,000 people 
for 2006 - 2009. Bars show standard error. 
 
2.2.3 Botulism 
The bacterium Clostridium botulinium is the causative agent of botulism. C. botulinium is not a well 
defined species of bacterium but rather refers to distinct groups of bacteria  that produce a total of 
seven distinct toxins (called A to G), all of which have similar pharmacological actions (Smith 1979). 
However, of these groups, only types A, B, E and more rarely F are capable of causing botulism in 
humans. Types C, D, E and G cause illness in other mammals, birds and fish (WHO 2002). 
C. botulinium are spore forming, anaerobic bacteria whose principal habitat is the soil, although their 
distribution can be highly regional. While the bacteria are soil borne, infection generally occurs 
through eating contaminated food, although it can also be transmitted directly into wound infections 
directly from the soil. 
Symptoms usually present within 12 – 36 hours and are caused by toxins produced by the bacteria 
rather than by the organisms themselves. However, thorough cooking of contaminated foods (heating 
to >85°C for five minutes or boiling for a few minutes) is sufficient to destroy the toxins as well as the 
bacteria (WHO 2002). Early symptoms usually include fatigue, weakness and vertigo, followed by a 
dry mouth and difficulty swallowing and speaking, and blurred vision. The disease can progress to 
weakness in the neck and arms after which respiratory muscles and muscles of the lower body become 
affected and this paralysis may make breathing difficult (WHO 2002). 
Antitoxin administration as soon as possible after diagnosis is necessary to ensure the best chance of 
recovery, although severe cases of the disease may also require supportive treatment such as 
mechanical ventilation for periods of weeks or even months. Administration of antibiotics is also 
necessary in the case of wound infection. 
The ECDC reported between approximately 100 and 130 infections per year attributed to botulism 
within the EU27 with 41 deaths having occurred between 1999 and 2008 as registered under the 
ICD10 codes in the WHO mortality database. Information concerning mean annual infection rates per 
country can be seen in Fig 3. 
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Fig 3: Mean annual infection rates of botulism in the EU27 by member state per 100,000 people 
for 2006 - 2009. Bars show standard error. 
 
2.2.4 Campylobacteriosis 
Bacteria from the genus Campylobacter, most commonly the species Campylobacter jejuni, are the 
causative agents of campylobacteriosis. It is an enteric bacterium and is one of the most common 
forms of bacterial infections in humans. Symptoms of campylobacteriosis usually present within 2-5 
days with only a relatively small number of organisms (1,000-10,000 bacteria) need to cause infection 
(Javid and Ahmen 2009). Symptoms include: fever, which can reach 40°C; headaches; and diarrhea, 
which is classified as inflammatory diarrhea which may be bloody (also known as dysentery). C. fetus 
may also cause bacteraemia (i.e. infection of the blood), usually as an opportunistic disease in 
immuno-compromised hosts, where it may be associated with systemic illness, meningitis, vascular 
infections, abscesses and/or nonspecific abdominal pain (Javid and Ahmen 2009). 
The main route of transmission of Campylobacter sp. are the ingestion of contaminated food or water 
(particularly undercooked poultry or unpasteurised milk), the faecal-oral route, or person to person 
contact. However, C. jejuni has been demonstrated to survive in the soil for at least 25 days, with 
indications that it can survive considerably longer (Ross and Donnision 2006) meaning that the soil is 
also a possible route of transmission, particularly owing to the relatively small infectious dose need to 
cause disease. 
Between 175,000 and 200,000 infections of campylobacteriosis were reported within the EU27 
between the years of 2006 and 2009, being the highest rate of infection of all of the soil borne diseases 
identified by this report which are tracked by the ECDC. However, despite this relatively high 
infection rate, only 46 mortalities were attributed to the diseases as logged on the WHO mortalities 
database under the ICD10 codes for the EU27 between 1998 and 2008. Information concerning mean 
annual infection rates per country can be seen in Fig 4. 
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Fig 4: Mean annual infection rates of campylobacteriosis in the EU27 by member state per 
100,000 people for 2006 - 2009. Bars show standard error. Data not available for France, Greece, 
Portugal or Spain. 
 
2.2.5 Escherichia coli  
Many strains of the bacterium Escherichia coli are harmless and in fact are prevalent within the human 
gut and do not causes diseases. However, some strains produce toxins which can causes disease in 
humans which in some cases can be severe depending on the host’s health before infection and the 
strain of E. coli, and the associated toxin, which is causing infection. 
The most common form of pathogenic E. coli is Enterotoxigenic E. coil (ETEC), which is the most 
common cause of bacterial diarrhea in children in the developing world as well as among travellers to 
developing countries (WHO 2009). ETEC accounts for several hundred million cases of diarrhea and 
tens of thousands of deaths globally each year (WHO 2009).  
Other serotypes of pathogenic E. coli include Enteropathogenic E. coli (EPEC) which causes diarrhea 
but also contains virulence factors which are similar to Shigella (discussed in more detail below; 
Section 2.2.12) and Verotoxigenic E. coli (VTEC) which causes bloody diarrhea (“Vero” indicates that 
this serotype produces the "Shig" toxin; See Section 2.2.12 for more information). 
The final serotype discussed in this report, known as Enterohaemorrhagic E. coli (EHEC), came to 
prominence most recently due to the strain 0104:H4 which caused the outbreak in Europe in 2011. 
This is a particularly virulent strain of the bacterium which was identified Germany and caused the 
third largest outbreak of E. coli with about 2200 infected patients, as well as one of the most lethal 
with at least 22 dead (as of 6/6/2011; Nettleman 2011). The infectious dose of only 10 to 100 bacteria 
needed to cause diseases, as opposed to over a million bacteria needed for most other pathogenic 
strains of E. coli demonstrates the relatively high virulence of this serotype (Greig et al. 2010). This 
new strain produces shiga toxin (and so is also VTEC) and is very similar to the 0157:H7 strain about 
which more is known. However, this strain also has the ability to attach to cells within the 
gastrointestinal tract in much the same way as Enteroaggregative (EAEC) strains (Nettleman 2011). It 
is this combination of factors which are likely responsible for the relatively high levels of virulence 
and mortality. While firm data are not currently included in this report, the strain clearly warrants 
monitoring and any updated versions of this report should include data where available. 
Although the main routes of transmission of E. coli are poor hygiene or sanitation leading to 
contamination of food or water, E. coil can also survive in the soil for sufficient periods of time to lead 
to infection even when the infectious individual that was the source of the contamination has long left 
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the area. The main factor affecting the length of time that E. coli can survive in soil appears to be soil 
moisture content, with cells surviving for 14 days in dry soils and longer in wet soils (Chandler and 
Carven 1980). However, Avery et al. (2004) demonstrated that the pathogenic strain O157 could 
survive on surface vegetation for up to 6 weeks, or in the underlying soil for 8 weeks. The survival of 
E. coli in compost heaps was also affected by moisture content but conversely the bacteria were 
capable of surviving higher temperatures at lower moisture contents, although survivability was 
generally measured in minutes as opposed to days at temperatures of 54-67°C (Gong et al. 2005). 
Only data on infection rates of VTEC are logged through TESSy and so are available through the 
ECDC. Approximately 3000 cases of VTEC were reported within the EU27 each year between 2006 
and 2009. The WHO logs mortalities due to enterohamorrhagic E. coli (7 deaths between 1997 and 
2006), enertoinvasive E. coli (10 deaths between 1999 and 2008), enteropathogenic E. coli (10 deaths 
between 1994 and 2006) and enterotoxigenic E. coli (1 death in 2002). Information concerning mean 
annual infection rates per country can be seen in Fig 5. 
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Fig 5: Mean annual infection rates of E. coli (VTEC type only) in the EU27 by member state per 
100,000 people for 2006 - 2009. Bars show standard error. Data not available for Czech 
Republic, Portugal or Spain. Note that data regarding the 0104:H4 strain which caused the 
outbreak in Europe in 2011 discussed by Nettleman (2011) are not included in this figure. 
 
2.2.6 Gas Gangrene  
The causative agent of gas gangrene is, in 80-90% of cases, the bacterium Clostridium perfringens 
(previously known as Clostridium welchii). The other 10-20% of cases are caused by the bacteria C. 
novio, C. septicum, C. histolyticum, C. bifermentans and C. fallax (Revis 2008). If untreated, gas 
gangrene is always fatal, although with treatment this mortality rate drops to 20-30% (60% if the chest 
or abdomen are infected; Revis 2008). 
C. perfringens, like other Clostridia species such as Clostridium botulinium, are bacilli which are gram 
positive, anaerobic and spore forming. They are highly prevalent in soils (DeSpain Smith and Gardner 
1949), as well as the intestinal tract of humans and animals (Bryan 1969). It has been reported that C. 
perfringens is more widely spread than any other pathogenic bacterium (Matches et al. 1974). 
However, no data are currently available in the literature as to the effects of land management 
practices on the abundance of this bacterium, nor which in which soil types or under which 
environmental conditions it is most prevalent. 
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More than 50% of cases occur as the result of trauma which introduces the bacteria into the body 
through wounds (Revis 2008). However, infection only occurs if the organisms are inoculated into a 
tissue where the oxygen tension is below 30%, such as in some deep cuts. Incubation is usually 
between 12-24 hours, although this can be as short as 1 hour in some instances, or may take several 
weeks (Revis 2008). Initial symptoms are usually the increasing of pain after surgery or a trauma, 
which is out of proportion to what would be expected from the surgery or wound, and which may have 
a sudden onset. Discolouration of the skin around the wound usually occurs, which can be purplish 
black and may also have the occurrence of blister like structures called bullae. 
The ECDC does not keep records of gas gangrene infection rates. The WHO reported 566 deaths due 
to gas gangrene under the ICD10 codes within the EU27 between the years 1994 and 2008. 
 
 
2.2.7 Leptospirosis 
Leptospirosis, also known as Weil’s diseases in its more serious form, is caused by a species of aerobic 
spirochete bacteria from the genus Leptospira. Bacteria of this genus are found in aquatic ecosystems 
as well as the soil, although they are generally found in higher abundances in the soil adjacent to water 
than the water itself (Henry and Johnson 1978).  
The genus Leptospira is most often divided into two complexes, the parasitic complex and the biflexia 
(non-parasitic) complex. The parasitic complex includes 13 named and 4 unnamed species (Agent 
2005), of which L. interrogans is the most well known, and has over 200 known pathogenic serologic 
variants (Agent 2005). 
Transmission of leptospirosis generally occurs through contact with fresh water, soil, or possibly 
vegetation which has been contaminated by the urine of infected animals. The bacteria are capable of 
surviving for at least 42 days in acidic soil (pH ~5.5; Hellstrom and Marshall 1978) and up to 74 days 
in more neutral soils (Zaĭtsev et al. 1989). This demonstrates that while pathogenic species require an 
infected individual to transfer them to the soil environment through their urine, they are then capable 
of surviving a considerable time after the infected individual has left the area until a susceptible host 
comes along and so fall under the classification of STPs. The fact that the bacteria can survive for 
extended periods in water means that they can be transported relatively large distances in times of 
floods, or through being transported via overland flow and in waterways. Increased risk of contracting 
the disease is associated with famers, vets, loggers, sewer workers and those that partake in water 
sports including fresh water swimming, kayaking and canoeing. 
Pathogenic Leptospira sp. can enter the body through ingestion of contaminated food or water, through 
broken skin or through mucous membranes. The bacteria then enter the blood and can migrate around 
the body, particularly to the kidneys, and within 7 to 10 days the bacteria can be passed in urine. 
Symptoms of the diseases can be very diverse and generally have two phases. The first phase usually 
involves flu-like symptoms including strong headache. The disease then passes through a brief 
moment in which the patient may be asymptomatic before the second phase begins which can include 
meningitis, renal failure and liver damage. 
The WHO registered 357 deaths within the EU27 between 1997 and 2008 under the ICD10 codes as 
attributed to leptospirosis (including Weil’s diseases and unspecified forms of leptospirosis). The 
ECDC registered between 541 and 844 cases of infection of leptospirosis between 2006 and 2009 in 
the EU27. Information concerning mean annual infection rates per country can be seen in Fig 6. 
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Fig 6: Mean annual infection rates of leptospirosis in the EU27 by member state per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for France or Spain. 
 
2.2.8 Listeriosis 
The causative agent of listeriosis is the gram-positive bacterium Listeria monocytogenes. Infection 
usually occurs in humans after eating food contaminated with the bacterium. It mainly affects infants, 
the elderly and immuno-compromised patients (Hof 1996). While it is a generally considered to be a 
food borne disease, the bacterium has been demonstrated to survive for extended periods in soil 
(Welshimer 1960) as well as being associated with sheep and cattle (Weinstein 2011). The main factor 
affecting the survival of Listeria monocytogenes in soil was found to be soil moisture content with 
survival averaging up to approximately 67 days in soils where the moisture content was not controlled 
as compared to up to 295 days in soils which were protected from evaporation (Welshimer 1960). 
Symptoms of listeriosis usually include fever, vomiting and myalgia which last for 7-10 days. 
However, in some instances the infection may spread to the nervous system where it can cause 
meningitis, or the blood, both of which are much more serious conditions. Overall the mortality rate of 
listeriosis is 20-30% with intravenous antibiotics being necessary as treatment. 
The ECDC had approximately 1,500 cases of infection registered annually between 2006 and 2009 in 
the EU27. The WHO reports 579 deaths in the EU27 reported under the ICD10 codes between the 
years 1996 and 2008. Information concerning mean annual infection rates per country can be seen in 
Fig 7. 
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Fig 7: Mean annual infection rates of listeriosis in the EU27 by member state per 100,000 people 
for 2006 - 2009. Bars show standard error. Data not available for Portugal or Spain. 
 
2.2.9 Lyme Disease 
Lyme disease is classified as a zoonosis, as it is transmitted to humans from a natural reservoir among 
rodents by ticks that feed on both sets of host. 
Lyme disease, or Lyme borreliosis as it is sometimes known, is an infectious disease which is caused 
by at least three species of spirochete bacteria belonging to the genus Borrelia. In the United States the 
causative agent of this disease is usually Borrelia burgdorferi is the main cause of Lyme disease, 
whereas most European cases are caused by either Borrelia afzelii or Borrelia garinii. Lyme diseases 
presents due to a combination of infection with Borrelia bacteria combined with the body’s immune 
response to the infection (Meyerhoff 2011). 
Transmission of the bacteria occurs through being bitten by an infected tick from the genus Ixodes. 
However, transmission is quite rare, with only about 1% of recognized tick bites resulting in Lyme 
disease. This is thought to be because an infected tick must be attached for at least a day for 
transmission to occur.  
Although ticks responsible for spreading Lyme disease are parasitic and hence rely on the presence of 
hosts for feeding, Guerra et al. (2002) demonstrated that the presence and abundance of the ticks was 
variable even when the host population was adequate and that the presence of ticks is positively 
associated with deciduous, dry to mesic forests and sandy or sandy loam textured soils.  
The ECDC does not track infections of Lyme disease. The WHO has 97 deaths attributed to Lyme 
disease (including “meningitis due to Lyme disease” and “other neurologic disorders in Lyme 
disease”) as having occurred in the EU 27 between 1995 and 2008. 
 
2.2.10 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a gram negative rod shaped bacterium which is widely distributed in soil 
and water around the world, as well as being found on plants and humans (Qarah and Cunha 2009). It 
is an opportunistic pathogen which rarely causes disease in healthy individuals but can cause a wide 
range of diseases in immuno-compromised individuals including respiratory tract infection, 
bacteraemia (infection of the blood), endocarditis (infection of the heart), urinary tract, gastrointestinal 
infection, as well as infecting bones, joints and the central nervous system. Therefore, it can be 
considered to be an EPO. 
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Symptoms usually include inflammation of the infected area and sepsis, and if critical organs become 
infected can be fatal (Balcht and Smith 1994). One characteristic of Pseudomonas aeruginosa which is 
of particular concern is its low antibiotic susceptibility (Hirulkar and Soni 2011). 
The ECDC does not track infections of Pseudomonas aeruginosa and the WHO does not track deaths 
attributed to it in its ICD10 codes beyond those “…as the cause of diseases classified to other 
chapters”. 
 
2.2.11 Q fever 
The causative agent of Q fever is the bacterium Coxiella burnetii which is a small, gram negative 
obligate intracellular parasite meaning that it has to infect the cells of a host in order to complete its 
life cycle. Therefore, it is classified as an STP.  
The disease was originally described in Brisbane, Australia where the pathogen was discovered in 
1937. It is considered to be a zoonotic disease with a reservoir in cattle, goats and sheep. The 
bacterium is found in all parts of the world with the exception of New Zealand (Greenslade et al. 2003) 
and Antarctica (Jones et al. 2011). 
Coxiella burnetii is very hardy and resistant to heat, desiccation and many common disinfectants, and 
so is able to persist in the environment, including soil, for up to 150 days (Jones et al. 2011). Infection 
occurs from the inhalation of the bacteria in spore form, usually from farmyard dust. The presence of 
vegetation and increased soil moisture appear to reduce the transmission of Coxiella by reducing the 
amount of dust available for dispersion of the bacteria (van der Hoek et al. 2011). The bacterium can 
also be contracted through contact with milk, urine or bodily fluids of infected animals as well as 
through ticks. The bacterium is highly virulent in humans with an infective dose of just one organism 
being necessary to cause disease in some instances (Tigertt et al 1961). 
Symptoms of acute Q fever usually appear 2-3 weeks after infection, although as many as half of the 
people infected with C. burnetii do not show symptoms. If symptoms do present they can vary greatly 
from person to person and can include high fever, severe headache, nausea, vomiting, diarrhea, 
abdominal and/or chest pain, myalgia, chills and/or sweats and a non-productive cough. 
Most individuals who develop Q fever recover with the antibiotic doxycycline usually being very 
effective as treatment. However, complications may occur including pneumonia, inflammation of the 
liver or heart or central nervous system complications. Q fever can also occur in a chronic form which 
occurs in <5% of infected patients, particularly in pregnant women, immuno-compromised patients 
and people with pre-existing heat valve defects, and usually presents as endocarditis.  
The ECDC reports that approximately 600 cases of Q fever infection occurred annually within the 
EU27 in 2006 and 2007 and then there was a large increase to 1667 cases in 2008 and 1962 in 2009 
with the majority of cases being reported in The Netherlands which saw a more than 100 fold increase 
in infection rate across those 4 years. The WHO reported 11 deaths in the EU27 reported under the 
ICD10 codes between the years 1999 and 2007. Information concerning mean annual infection rates 
per country can be seen in Fig 8. 
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Fig 8: Mean annual infection rates of Q fever in the EU27 by member state per 100,000 people 
for 2006 - 2009. Bars show standard error. Data not available for Austria, Denmark, France, or 
Spain. 
 
2.2.12 Salmonellosis 
Salmonellosis, sometimes called salmonella, is caused by a group of gram-negative motile bacteria 
from the genus Salmonella. The genus includes many species of bacteria and each species may contain 
many serotypes. For example, the species S. enterica has over 2,500 different serotypes described, 
some of which are host restricted and others of which may have a very broad host range (Grassi and 
Finlay 2008).  
Salmonella, along with E. coli and Campylobacter, are the most common forms of food borne illness. 
Although humans generally contract salmonellosis through eating contaminated food, one of the main 
routes in which pathogenic Salmonella bacteria come into contact with vegetables is from the soil 
(Islam et al. 2004). 
Salmonella sp. along with other human enteric pathogens such as E. coli and Campylobacter, are often 
introduced into the soil with liquid manure on agricultural land (Bech et al. 2010). Once introduced 
into the soil, pathogenic species of Salmonella have been demonstrated to be able to persist for up to 
231 days and to be capable of contaminating vegetables grown in such soils (Islam et al. 2004). 
Salmonellosis presents as one of three distinct syndromes, typhoid (enteric) fever, non-typhoidal 
enterocolitis, or non-typhoidal focal disease (Klotchko and Wallace 2011), all of which are caused by 
different serotypes of salmonella bacteria. 
Typhoid fever can present with nonspecific features such as diarrhea, vomiting or respiratory 
symptoms. Approximately 10-15% of patients develop severe diseases which presents with persistent 
and high fever which generally is accompanied by relative bradycardia (slower than normal heart rate) 
as well as rose spots on the back, arms and legs in 25% of cases. The tongue is usually coated, the 
abdomen tender and the liver and spleen may become inflamed. 
Non-typhoidal enterocolitis usually presents with loose bloodless stools. In rare instances large volume 
diarrhea may also be present which typically resolves in 3-7 days. Fever, headache, abdominal cramps 
and myalgia are also common with the fever usually resolving itself within 48 hours. 
Non-typhoidal focal disease occurs due to bacteraemia if salmonella bacteria enter the blood. It may 
affect almost any organ with organs which have pre-existing structural anomalies are generally most 
vulnerable and prone to being affected (Klotchko and Wallace 2011). 
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A decline in the incidence of salmonella infection between 2006, where approximately 162,000 cases 
of infection were recorded, down to approximately 110,000 cases in 2009 within the EU27 (ECDC 
2011). 960 deaths were recorded by the WHO under the ICD 10 codes as attributed to salmonella 
infection (all types) between the years 1994 and 2008. Information concerning mean annual infection 
rates per country can be seen in Fig 9. 
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Fig 9: Mean annual infection rates of salmonellosis in the EU27 by member state per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for Spain. 
 
2.2.13 Shigellosis 
Shigellosis is caused by one of four different species of bacteria from the genus Shigella: S. flexneri 
(also known as “Type B”); S. sonnei (also known as “Type D”); S. boydii; and S. dyseneriae. These 
bacteria are capable of causing an acute intestinal disease which may present with symptoms ranging 
from relatively mild abdominal pains, up to stomach cramps, diarrhea, fever, vomiting and blood in 
stools. In its more extreme presentations shigellosis is often referred to as dysentery (which is an 
umbrella term for similar symptoms caused by a range of viruses, bacteria or protozoa), and can be 
fatal if left untreated 
Transmission of shigella bacteria can occur through eating infected food, contaminated soil or water, 
or human to human transmission can occur through blood, saliva, sexual contact, the faecal-oral route 
or from the mother to fetus. Shigellae bacteria have been found to survive for up to approximately 40 
days in the soil, with the strain of bacteria having a greater influence on their viability than soil type 
and temperature (Leonardopoulos et al. 1980). This means that soil may remain as a source of 
infection even after an infectious individual may have long left the area. 
Shigella species are responsible for approximately 165 million cases of severe dysentery globally each 
year. The majority of these cases occur in developing countries in children under 5 years of age; more 
than one million people are estimated to die from Shigella infection each year. Within the EU27 
approximately 6,000 – 8,000 cases of Shigella infection were reported annually between 2006 and 
2009 according to data available from the ECDC. However, only 85 deaths have been attributed to 
Shigella within the EU27 since 2000 (WHO 2011). These relatively low infection and mortality rates 
when compared to the global average are likely due to the improved sanitation generally found within 
the EU27 when compared to the developing world, and the ready access to medical facilities to counter 
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dehydration (the main risk associated with Shigella infection due to the diarrhea it causes), as well as 
the ready access to antibiotics which are responsible for the greatly reduced mortality rates seen within 
the EU27 despite S. dysenteriae Type 1 having formed resistance to several antimicrobial drugs 
including ampicillin, chloramphenicol, streptomycin, tetracycline and sulfadiazine (Olarte et al. 1976). 
Information concerning mean annual infection rates per country can be seen in Fig 10. 
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Fig 10: Mean annual infection rates of shigellosis in the EU27 by member state per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for Italy. 
 
2.2.14 Tetanus 
Clostridium tetani is the causative agent of the diseases tetanus. C. tetani bacteria, as all other species 
of Clostridium, are spore forming, gram positive and obligate anaerobes.  
The C. tetani bacterium, which has a global distribution, is generally found in the soil as well as in 
animal waste. The association that many people have with tetanus and rusty metals is somewhat 
misconstrued. The bacterium does not have any propensity to grow on rusty metal, but rather owing to 
its highly resilient spores is capable of surviving on rusty metal. The rusty metal itself sometimes 
provides a means of infection through piercing the skin of individuals who cut themselves on the metal 
or stand on rusty nails etc. 
The tetanus disease is caused by a toxin which is produced by the bacterium and affects the central 
nervous system. The incubation period can vary from a few days to a few weeks. The first signs of 
tetanus infection are usually general tiredness or weakness, followed by muscle spasms. The spasms 
can be particularly prevalent in the jaw muscles at the onset of the disease, causing the jaw to become 
tightly closed due to these muscle spasms and leading to the alternative name for the diseases 
“lockjaw”. 
Diagnosis of tetanus is based on the presentation of symptoms as there are currently no blood tests 
which are capable of detecting tetanus. Furthermore, C. tetani bacteria are only recovered from the 
wound in approximately 30% of cases, as well as occasionally being isolated from wounds of 
individuals who do not have symptoms of tetanus which is testament to how widespread this species of 
bacteria is. 
Tetanus is a preventable condition owing to the availability of an effective vaccine. Most people within 
the developed world are offered vaccination against tetanus as a part of each countries standard 
vaccination schedule. Infection with tetanus as registered with the ECDC has seen a continuous 
decline within the EU27 from 163 infections in 2006, down to 78 infections in 2009. However, 412 
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deaths are registered in the WHO mortality database as attributed to “other tetanus” under the ICD 10 
codes between the years 1996 and 2008. Information concerning mean annual infection rates per 
country can be seen in Fig 11. 
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Fig 11: Mean annual infection rates of tetanus in the EU27 by member state per 100,000 people 
for 2006 - 2009. Bars show standard error. Data not available for Austria, Finland or Germany. 
 
2.2.15 Tularemia 
Tularemia is caused by the bacterium Francisella tularensis which is a non-motile gram-negative 
coccobacillus of which several serotypes exist, each with varying degrees of virulence. The bacterium 
is a facultative intracellular pathogen which causes tularemia in humans and animals. The diseases is 
something known as rabbit fever, or deer fly fever owing to the fact that the primary vectors are deer 
flies or ticks, as well as other arthropods. As well as bites from arthropods, the diseases can be 
contracted through direct contact between a break in the skin with an infected animal or its dead body 
(most often rabbits, hence the name rabbit fever; Schaffner 2007). The disease may also be contracted 
through inhalation or ingestion of infected contaminated dust or soil (Reintjes et al. 2002). Inoculation 
or inhalation of as few as 10 cells of F. tularensis bacteria can be sufficient to cause disease in humans 
(Abd et al. 2002). 
The bacterium is known to survive for weeks at low temperatures in water, soil and animal carcasses, 
and for more than a year in mud in some instances (Parker et al 1951). Evidence suggests that the main 
reservoir of the bacterium in the environment may be the cells of protozoa, particularly the protozoa 
Acanthamoeba castellanii which is ubiquitous in the environment (Abd et al. 2002). 
The incubation period after infection is usually 3 to 5 days after exposure and the illness usually starts 
very suddenly and may continue for several weeks. Symptoms include chills, fever, headache, joint 
stiffness and muscle pain and red spots on the skin which grow to become ulcers. Tularemia is fatal in 
approximately 5% of untreated cases, but less than 1% of treated cases (Dugdale et al. 2011) 
Between approximately 550 (2006) and 1200 cases (2007) were been reported within the EU 27 
between 2006 and 2009. The disease is generally cured with antibiotics, although a high relapse rate 
has been observed with tetracycline and chloramphenicol (Dugdale et al. 2011). Only 5 deaths were 
recorded by the WHO under the ICD 10 codes as attributed to tularaemia between the years 1995 and 
2003 within the EU27. Information concerning mean annual infection rates per country can be seen in 
Fig 12. 
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Fig 12: Mean annual infection rates of tularemia in the EU27 by member state per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for Denmark, The 
Netherlands or Portugal. 
 
2.2.16 Yersiniosis 
Yersinia enterocolitica is the causative agent of yersiniosis. It is a species of gram negative 
coccobacillus bacterium which is part of the family Enterobacteriaceae, along with Salmonella and E. 
coli. It is a zoonotic disease which can be transmitted from many different animal including pigs, cattle 
and deer. Yersinia enterocolitica consists of a relatively diverse group of bacteria which can be divided 
into either 18 or 54 different serotypes depending on the criteria used (Weagant and Feng 2001). 
The survival of Yersinia enterocolitica in soil is strongly affected by environmental conditions, 
particularly soil moisture, as the bacterium does not cope well with desiccation. For example, it has 
been demonstrated that air drying soil over 10 days reduced the number of viable cells to only 0.1% of 
the original population (Chao et al. 1988), although different strains of the bacterium have different 
survival rates (Tahiro et al 1991). 
Symptoms usually develop between 4 and 7 days after infection which usually occurs through 
ingestion of the bacteria, usually from undercooked food, particularly pork products. Symptoms of 
yersiniosis include fever, diarrhea (which may be bloody) and abdominal pain. In some instances joint 
pain, particularly in the knees, wrists or ankles may also occur, although this is relatively rare. A skin 
rash may also occur on the legs and torso, which is also rare but slightly more common in women than 
men. 
The disease usually resolves itself within 1 to 3 weeks, although is some cases treatment through the 
use of antibiotics is required, particularly in susceptible individuals such as those who are immuno-
compromised. In very young infants (i.e. <3 months or so in age) the bacteria is sometimes capable of 
infecting the blood (bacteraemia) and as such young infants who contract the diseases may require 
hospital treatment. 
Between approximately 7,600 and 9,000 cases of yersiniosis were reported within the EU27 annually 
between 2006 and 2009 according to the ECDC. The WHO registered 340 deaths in the EU27 between 
1994 – 2008, under the ICD10 codes, as being attributed to enteritis caused by Yersinia enterocolitica. 
Information concerning mean annual infection rates per country can be seen in Fig 13. 
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Fig 13: Mean annual infection rates of yersiniosis in the EU27, by member state, per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for France, Greece, The 
Netherlands or Spain. 
 
2.2 Protozoa 
Protozoa are a highly diverse group of single celled eukaryotic organisms such as amoebae. They are 
distributed globally and are found in high abundances in soils where they feed on bacteria, fungi and 
organic matter within the soil and in turn provide a food source for other soil invertebrates. Some 
species are pathogenic in humans, however, the most famous of which being Plasmodium sp., the 
causative agents of malaria. However, unlike the Plasmodium sp. which has mosquitoes as a vector, 
several groups can be soil borne, and these are discussed in more detail below. 
 
2.2.1 Amoebiasis 
The causative agent of amoebiasis is the protozoan Entamoeba histolytica which is found worldwide 
and is an anaerobic parasitic protozoan. The highest incidences of amoebiasis are in the developing 
world, particularly in areas where there is inadequate sanitation and hygiene. Amoebiasis is second 
only to malaria with regard to deaths caused by protozoa globally (Lacasse and Cleveland 2009) 
although deaths from amoebiasis are relatively rare within the EU27. 
Infection with E. histolytica can be asymptomatic or may cause diarrhea and abdominal pain. 
However, dysentery can occur in some cases as well as invasive extra intestinal disease, which most 
commonly involves the liver but may also affect other organs (Lacasse and Cleveland 2009). 
Infection generally occurs through the faecal-oral route which may involve the organism being in the 
soil for some time, although other routes of transmission have also been reported (Lacasse and 
Cleveland 2009). E. histolytica is capable of forming cysts and in this form can survive for weeks or 
months in soil (Beaver and Deschamps 1949), and so infect hosts who later consume food or water 
contaminated with such soil. 
The ECDC does not track infection rates of amoebiasis. The WHO registered 20 deaths as being 
attributed to amoebiasis within the EU27 under the ICD10 codes between 2000 and 2007, including 
amoebic liver and lung abscesses and amoebic non-dysenteric colitis.  
. 
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2.2.2 Balantidiasis 
Balantidiasis is caused by the ciliated protozoan Balantidium coli. It is found worldwide but is most 
common in Latin America, Southeast Asia, The Philippines and Papua New Guinea. It is thought that 
pigs are the most likely reservoir of this protozoan (Chijide 2008). However, under favourable 
conditions with regard to temperature and humidity Balantidium coli can survive for weeks to months 
in soil in cyst form (Goldsmith 1997). 
Infection with B. coli is often asymptomatic. However, some individuals may present with diarrhea, 
which may be watery or bloody and which may lead to severe fluid loss, as well as with nausea and 
vomiting. Abdominal pain may be present, along with loss of appetite, headache and fever.  
The ECDC does not track infection rates of balantidiasis. The WHO has no registered deaths as being 
attributed to balantidiasis within the EU27 under the ICD10 codes. However, it should be noted that 
the WHO does have deaths registered to non-specific diseases such as “Diarrhoea and gastroenteritis 
of presumed infectious origin” of which over 11,000 deaths have occurred within the EU27 between 
1994 and 2008 and which may include balantidiasis. This means that it is not possible to say with 
confidence that no deaths have occurred due to balantidiasis within the EU27 in recent years. There is 
insufficient clarity in the data to be able to draw a conclusion in this regard. 
 
2.2.3 Cryptosporidiosis 
Cryptosporidiosis is caused by spore-forming protozoa from the genus Cryptosporidium such as C. 
parvum and C. muris. As with the other protozoan diseases it is usually spread through the faecal-oral 
route and so is most prevalent in areas of poor sanitation where it mostly affects children (Cabada and 
White 2011). 
Infection with Cryptosporidia is often asymptomatic. For those infected individuals that do present 
with symptoms diarrhea is the most common which is often watery and incapacitating. Nausea, low 
grade fever and abdominal cramps are also common symptoms. Symptoms usually last for 5-10 days, 
although they may persist for up to 4 weeks (Cabada and White 2011). 
In cyst form, Cryptosporidia is capable of surviving in soil for weeks or months. Like other protozoa, 
while in cyst form Cryptosporidia are non-motile. However, they have been found to leach down 
through soil due to rainfall (Mawdsley et al. 1996) and as such may possibly migrate from the initial 
area of contamination, particularly if they enter a water source such as a river. 
The ECDC does not track infection rates of cryptosporidiosis. The WHO registered 10 deaths as being 
attributed to Cryptosporidiosis within the EU27 under the ICD10 codes between 1999 and 2006, 80% 
of which occurred within the United Kingdom between 2002 and 2006. 
 
 
2.2.4 Cyclosporiasis 
Cyclosporiasis is caused by the coccidian protozoan Cyclospora cayetanensis which only infects 
humans (Shoff and Behrman 2010). As with the other protozoan diseases it is usually spread through 
the faecal-oral route and so is most prevalent in areas of poor sanitation. The protozoan is capable of 
surviving for extended periods in soil and as such contact with contaminated soil has been suggested to 
be an important mode of transmission (Chacin-Bonilla 2007; 2010). 
Infection with Cyclospora cayetanensis usually presents with diarrhea which may be explosive and 
accompanied with abdominal cramps, fatigue, malaise and weight loss and which may be interspersed 
with periods of remission. The diarrhea may persist for weeks to months if left untreated (Shoff and 
Bahrman 2010). 
The ECDC does not track infection rates of cyclosporiasis. The WHO has no registered deaths as 
being attributed to cyclosporiasis within the EU27 under the ICD10 codes. However, as above for 
balantidiasis, it should be noted that the WHO does have deaths registered to non-specific diseases 
such as “Diarrhoea and gastroenteritis of presumed infectious origin” of which over 11,000 deaths 
have occurred within the EU27 between 1994 and 2008 and which may include cyclosporiasis and as 
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such it is not possible to say that no deaths have occurred due to cyclosporiasis within the EU27 in 
recent years. There is insufficient clarity in the data to be able to draw a conclusion in this regard. 
 
 
2.2.5 Giardiasis 
The causative agent of giardiasis is the flagellate protozoan Giardia lambila which is the most 
common protozoan intestinal parasite worldwide. It is a zoonotic disease which has been isolated from 
the stools of various animals including cats, dogs, sheep, cattle and various rodents. 
Giardia lambila is found throughout the world. It does not strongly bind to soil particles and so in the 
event of rainfall leading to overland flow, the protozoan is easily washed away and so can be 
transported for long distances (Dai and Boll 2006). Cysts of G. lambila are capable of surviving for up 
to 3 months in water at 4°C. While data on survivability in soil is not currently available it seems likely 
that it will survive for a similar amount of time in soil in its resistant spore form, although this may 
well be dramatically reduced in dry soils (Sattar 1999). 
Giardiasis usually presents with a broad spectrum of symptoms with some people experiencing an 
abrupt onset of explosive watery diarrhea with abdominal cramps, vomiting, fever, malaise and foul 
flatus which last for 3-4 days before transition into the more common symptoms of giardiasis. 
However, most people experience a slower onset of symptoms. These include stools which become 
malodorous, mushy and greasy which may alternate with watery diarrhea and constipation. Upper and 
mid abdominal cramps may occur, as well as sulphurous belching, substantial burning and acid 
indigestion as well as loss of appetite, fatigue and malaise. 
Between approximately 14,400 and 18,100 cases of giardiasis were logged at the ECDC within the 
EU27 between 2006 and 2009. The WHO registered 3 deaths as being attributed to giardiasis within 
the EU27 under the ICD10 codes between 2004 and 2006, all of which occurred within the United 
Kingdom. Information concerning mean annual infection rates per country can be seen in Fig 14. 
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Fig 14: Mean annual infection rates of giardiasis in the EU27 by member state per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for Denmark, France, Italy, 
Portugal or Spain. 
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2.2.6 Isoporiasis 
Isoporiasis is a relatively uncommon illness caused by the coccidian protozoan Isospora belli. Humans 
are the only known hosts for the protozoan which is distributed globally, but more common in the 
tropics and subtropics. The protozoan is an obligate intracellular parasite meaning that it must enter a 
human cell in order to complete its lifecycle. However, the organism also has an external stage 
whereby oocysts need to enter the external environment, usually water contaminated with faeces, but 
also possibly soil, in order for the oocysts to mature (Tolan et al. 2011). 
As with other infectious protozoa, the main route of infection is the faecal-oral route. No data is 
currently available on the survivability of I. belli in soil, but as with other protozoa it is likely to be soil 
moisture dependent, with moist soil favouring longer survival times. 
The diseases usually presents with profuse, watery, offensive smelling diarrhea with abdominal 
cramps, loss of appetite and low grade fever. Headache and myalgia may also present, although more 
rarely. The incubation period of the diseases ranges from 3 – 14 days and symptoms usually persist for 
2-3 weeks (Tolan et al. 2011) 
The ECDC does not track infection rates of isoporiasis and the WHO has no deaths registered as being 
attributed to isoporiasis within the EU27 under the ICD10 codes. 
  
2.2.7 Toxoplasmosis 
Toxoplasmosis is caused by the protozoan Toxoplasma gondii which is an obligate intracellular 
parasite. Humans are only intermediate hosts of the protozoan, along with other mammals, with cats 
being the primary hosts. 
T. gondii is very common and it is estimated that approximately one third of the world’s population of 
humans have been exposed to it (Montoya and Liesenfeld 2004). However, the disease is usually 
asymptomatic with symptoms only usually presenting in immuno-compromised individuals and in new 
born infants who may acquire the disease in utero from their mothers. 
T. gondii has been shown to be detectable in soils where infected cats defecate and so can be highly 
localised (Afonso et al 2008). When in the soil, the oocysts of T. gondii have been found to be able to 
survive for at least 3 months (Lindsay et al. 2002) meaning that soils can remain infectious for long 
periods of time after the originally infected individual has left. 
Symptoms, when present, include flu-like symptoms with prominent lymphadenopathy (swollen 
lymph nodes). Ocular infection may occur and is usually painful and may lead to impaired vision and 
the presence of floaters. 
In immuno-compromised patients the central nervous system may become infected, leading to 
seizures, headaches and altered mental states. The lungs may also become infected leading to a non 
productive cough, chest discomfort and dyspnoea. 
Congenital toxoplasmosis can cause jaundice, developmental delay, visual defects including blindness, 
and cerebral calcification (Becker et al. 2010). 
Toxoplasmosis is relatively rare within the EU27 with only approximately 20 – 30 cases reported 
annually to the ECDC between 2006 and 2009. However, the WHO has 159 deaths reported as 
attributed under the ICD 10 codes to various forms of toxoplasmosis including toxoplasma 
meningoencephalitis, toxoplasma hepatitis and “toxoplasmosis with other organ involvement” between 
1996 and 2008 within the EU27. Information concerning mean annual infection rates per country can 
be seen in Fig 15. 
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Fig 15: Mean annual infection rates of toxoplasmosis in the EU27 by member state per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for Denmark, France, 
Germany, Greece, Italy, the Netherlands, Portugal or Spain. 
 
2.3 Fungi 
The fungi, like humans, are from the domain “Eukaryota”. This means that fungal cells are more 
similar to human cells then they are to bacterial cells. This means that complications arise with regard 
to treatment of fungal diseases as the two types of cell (human and fungus) are relatively similar when 
compared to bacterial cells. Therefore, that the chemicals which can be used to combat fungal 
infection are relatively limited when compared to the antibiotics used to fight bacterial infection, as 
they need to be able to attack the invading fungal cells without doing too much damage to the bodies 
own cells. 
 
A little over 400 species of fungi are known to cause diseases in animals and far fewer cause diseases 
in humans. Generally they are caused by opportunistic pathogenic strains of fungi which pose the 
greatest risk to immuno-compromised patients. A rise in the incidence of these diseases had been 
reported (Low and Rotstein 2011), with one possible explanation for this rise being the increase in the 
number of patients that are immuno-compromised as a result of chemotherapy, taking anti-rejection 
drugs post transplant, people with AIDS and other long term health conditions such as diabetes (Low 
and Rotstein 2011). Many fungal diseases which occur in humans are superficial, affecting the skin, 
nails or hair, such as ringworms (generally caused by Microsporum canis) and “athlete’s foot” (caused 
by Trichophyton mentagrophytes and Trichophyton rubrum; Pelayo Ulacia and Dafhnis 1980), with 
only relatively few fungal diseases which are potentially fatal in humans. 
The majority of human pathogenic fungi are soil in habiting saprotrophs (i.e. they feed on dead organic 
matter within the soil). However, when coming into the contact with immuno-compromised patients or 
other susceptible individuals, such as in an open wound or through the inhalation of spores, some fungi 
can become very aggressive forms of infection. Furthermore, owing to the eukaryotic nature of fungi, 
meaning that their cells are more similar to human cells as previously discussed, many antibiotics are 
ineffective and different antifungal medication is required.  
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2.3.1 Aspergillosis 
The name aspergillosis relates to an infection, growth or allergic reaction caused by a fungus of the 
genus Aspergillus. Aspergillus fungi are relatively common in soils and leaf litter all around the world 
including forest, wetland, cultivated soils and particularly in desert soils (Klich 2002). In the soil 
Aspergillus sp. function as saprophytes, and as with most other soil fungi play an important role in the 
breakdown of organic matter. 
Despite being very wide spread globally, meaning most people are frequently exposed to the fungus, 
infections only occur very rarely in people with normal immune systems (Zieve et al 2010). 
Aspergillosis can occur in three different forms in humans. Pulmonary aspergillosis – allergic 
bronchopulmonary type, which is an allergic reaction to the fungus which may develop in people who 
already have lung problems such as cystic fibrosis or asthma; Pulmonary aspergillosis – invasive type, 
which is a serious infection with pneumonia which may spread to other parts of the body. This type 
occurs almost exclusively in immuno-compromised patients such as those with AIDS, those 
undergoing chemotherapy or on medication after organ transplants; and finally Aspergilloma, which is 
a growth of fungus that develops in an area where previous lung damage has occurred through lung 
disease such as tuberculosis or a lung abscess (Zieve et al. 2010). 
The ECDC does not track infection rates of aspergillosis within the EU27. The WHO logged 2,357 
deaths under the ICD10 codes as attributed to aspergillosis (all forms) between the years of 1994 and 
2008 within the EU27. 
 
2.3.2 Blastomycosis 
Blastomycosis refers to fungal infections caused by the dimorphic fungus Blastomyces dermatitidis, 
which is endemic to portions of North America (Kayser et al. 2005) or the fungus B. brasiliensis (also 
known as Paracoccidioides brasiliensis) which is endemic to some areas of South America (Kayser et 
al. 2005). Dimorphic refers to the ability of these fungi in two undertake growth forms, either hyphal 
growth like a mould, or single cellular growth like a yeast.  
Infection can be caused by either spores or mycelium from the soil and may occur in any part of the 
body, although primary infection tends to be pulmonary due to transmission from the soil via 
inhalation. Less commonly infection may occur through the skin after trauma should infectious cells 
enter the wound (Steele and Shetty 2011). Symptoms normally include low grade fevers, chest pain, a 
mild but persistent productive cough and haemoptysis (i.e. coughing up of blood) (Feng et al. 2007). 
Secondary infections may also be detected as lesions in the skin which may remain localised or, in 
some instances, may spread throughout the body leading to extensive ulceration (Steele and Shetty 
2011). It has been reported that males are more susceptible to infection with the ratio being as high as 
10 infected males for every 1 infected female (Morris et al. 2004), a fact which is generally attributed 
to males being more likely to be associated with activities with an increased risk of infection such as 
hunting, camping and logging (Fang et al. 2007). In South America, blastomycosis is most commonly 
observed among famers. There is no evidence of transmission of the diseases from either infected 
humans or infected animals to other humans, even if they are susceptible to the diseases, i.e. through 
being immuno-compromised (Kayser et al 2005). There is currently no effective treatment for 
blastomycosis. 
The ECDC does not track infection rates of blastomycosis within the EU27. The WHO has 9 deaths 
registered in its mortality database under the ICD 10 codes attributed to blastomycosis in various 
forms (e.g. acute pulmonary blastomycosis, disseminated blastomycosis) between 2001 and 2008. 
However, it is not possible to say whether these individuals were also infected from within the EU27 
or whether they contracted the disease from other areas where the fungus is more common or endemic. 
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2.3.3 Coccidioidomycosis  
The causative agents of coccidioidomycosis (also known as valley fever, among other names) are the 
fungi Coccidiodes immitis and Coccidiodes posadasii (Oppenheimer et al. 2010). Both species of 
fungus are morphologically identical but are distinct both genetically and epidemiologically. C. 
immitis is endemic to the San Joaquin valley region of California, whereas C. posadasii is endemic to 
desert areas of South and Central America, Northern Mexico and the south west of the United States of 
America (Oppenheimer et al. 2010). Cases of coccidioidomycosis have been reported in Europe, but 
these have been associated with patients who have travelled to the United States of America and other 
places where the fungus is endemic (Asgari et al. 2001). 
The number of cases of coccidioidomycosis have been reported to increase markedly in the later 
summer and early autumn (i.e. the dry season) where soil disturbances due to wind erosion, or other 
anthropogenic factors, such as agricultural practices, are thought to make the fungus airborne and 
thereby increases the risk of its inhalation (Oppenheimer et al. 2010).  
Infection usually presents as an acute but benign and respiratory disease which is generally self-
limiting. Furthermore, once the infected individual recovers, they are likely to be permanently immune 
from further infection by the same fungus. 
The ECDC does not track infection rates of coccidioidomycosis within the EU27. The WHO has 4 
deaths registered in its mortality database under the ICD 10 codes attributed to coccidioidomycosis. 
However, as with the case for blastomycosis, it is not possible to say whether these individuals were 
also infected from within the EU27 or whether they contracted the disease from other areas where the 
fungus is more common or endemic. 
 
2.3.4 Histoplasmosis 
Histoplasmosis is caused by the fungus Histoplasma capsulatum. It is also known as Darling’s 
diseases, Ohio valley diseases or Cave disease. The disease primarily affects the lungs after infection 
due to the inhalation of spores disturbed from the soil or from bird or bat droppings. The fungus is 
endemic to the Ohio, Missouri and Mississippi river valleys in the United States as well as in caves in 
southern and East Africa and other river valleys of North and Central America, eastern and southern 
Europe, eastern Asia and Australia (Fayyaz and Lessnau 2010). 
Histoplasma capsulatum is a dimorphic fungus which grows in mycelial form while in the soil at 
ambient temperatures but which grows in a single celled yeast form at body temperature in mammals 
(Fayyaz and Lessnau 2010). While the most infectious soil occurs in areas inhabited by birds and bats, 
birds cannot transmit the diseases, while bats can. Bird excrement, however, enriches the soil and 
provides favourable conditions for the fungus to grow, i.e. acidic damp soil which is high in organic 
matter. In contrast, bats can become infected with the fungus and can transmit it through their guano. 
Owing to the fact that Histoplasma capsulatum can survive well and even thrive within the soil, 
contaminated areas be remain infectious for years (Fayyaz and Lessnau 2010). 
Approximately 90% of people infected with Histoplasma capsulatum remain asymptomatic with 
histoplasmosis usually only developing in immuno-compromised individuals. When symptoms occur 
they can take different forms; either acute or chronic pulmonary histoplasmosis where symptoms 
include fever, chills, cough (including possibly coughing up of blood), and chest pain which is usually 
associated with inhalation (Dugdale et al. 2008); or disseminated histoplasmosis where the fungus 
spreads beyond the lungs via the blood and may affect multiple organs, and may include headache, 
neck stiffness, mouth sores and skin lesions (Dugdale et al. 2008). Disseminated histoplasmosis is 
usually fatal if left untreated (Kauffman 2007). 
Data on infection rates is not kept by the ECDC. The WHO has 9 deaths logged under their ICD10 
codes as attributed to histoplasmosis between the years of 2000 and 2007 in the EU27. 
 
 35
2.3.5 Sporotrichosis 
Sporotrichosis is a chronic fungal skin infection which is caused by the fungus Sporothrix schenckii. 
The fungus is wide spread in the soil with a global distribution (Lima Barros et al. 2011) and may also 
be found on plant materials such as hay. Infection usually occurs via infection through broken skin 
while handling plant materials and as such is often associated with farmers, horticulturalist and 
gardeners. Disseminated sporotrichosis (i.e. sporotrichosis which has spread through the infected 
individual’s body) may also occur in immuno-compromised people who inhaled dust containing 
spores. 
Symptoms usually include a red lump which develops at the site of infection and which eventually 
turns into an ulcer. As the fungus sometimes grows through the lymphatic channels in the body small 
ulcers may appear in lines on the skin passing up a leg or arm from the initial site of infection. 
Treatment is required to allow such sores or ulcers to heal which takes the form of antifungal medicine 
such as itraconazole or fluconazole. Disseminated sporotrichosis may lead to lung and breathing 
problems as well as infection of bone or the central nervous system. 
The ECDC does not track infection rates of sporotrichosis. The WHO has only 1 death registered as 
attributed to sporotrichosis under the ICD 10 codes as occurring within the EU27 which occurred in 
Poland in 2002 (Lymphocutaneous sporotrichosis) demonstrating that the disease is only very rarely 
fatal.  
 
2.3.6 Mucormycosis 
Mucormycosis is the name given to a range of diseases which are caused by fungi of the order 
Mucorales, which is the largest order of zygomycete fungi, and which are sometimes referred to as pin 
moulds. Mucoralean fungi are generally saprotrophic and grow on organic matter such as dead plant or 
animal material within soil. However, some species of Mucorales are parasites or pathogens of plants 
or animals, including humans. Fungi from the genera Rhizopus are the most common causative agents 
of these diseases although fungi from the genera Mucor, Absidi and Cunninghamella are also 
frequently implicated in causing diseases (Crum-Cianflone 2008).  
Infection usually occurs in the lungs, sinuses or brain, although may also occur in the gastrointestinal 
tract and other organs, and is most common in immuno-compromised patients such as those with 
undergoing cancer treatment, or suffering from AIDS. 
Mucormycosis is very rare but has a high mortality rate (50-85%) which can be even higher in 
individuals with gastrointestinal or pulmonary infection (Crum-Cianflone 2008). It is necessary for 
infected tissues to be removed for survival combined with medical therapy including antifungal 
medication. Infections have been found to increase in areas after tornados which can lift spores from 
the soil into the air where they can then infect wounds of individuals struck be debris as a result of the 
tornado (Williams 2011). 
The ECDC does not track infection rates of mucormycosis. Owing to the rarity of infection only 11 
mortalities are registered with the WHO between 1998 and 2006 under the ICD10 codes within the 
EU27, despite its high mortality rate once individuals are infected. 
 
2.3.7 Mycetoma 
Mycetoma refers to two diseases, caused by either actinomycetes or fungi, which result in chronic 
subcutaneous infection. Mycetoma which is caused by actinomycetes is called actinomycetoma and 
that caused by true fungi is called eumycetoma. More that 20 species of fungi and actinomycetes can 
cause mycetoma, with actinomycetes causing almost three times as many cases of the disease as true 
fungi (Ania et al. 2008). Mycetoma may result from the infection of one of a number of different soil 
dwelling actinomycetes or fungi including organisms of the genera Nocardia, Streptomyces, 
Madurella and Pseudoallecheria. 
The disease is most common in Africa, but is also found in Central and South America, India, and the 
Middle and Far East. It is most common between latitudes of 15°S and 30°N. 
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The disease usually presents with subcutaneous swelling which is painless, and usually occurs at the 
site where a previous penetrating injury has occurred which has inoculated the actinomycete or fungus 
into the wound. Development of the disease takes place over several years and can eventually lead to 
massive swelling and possible skin rupture. 
The ECDC does not track infection rates of mycetoma. The WHO registered 78 deaths as being 
attributed to mycetoma within the EU27 under the ICD10 codes between 1997 and 2007 (including 
nocardial mycetoma). 
 
2.4 Helminths 
The name helminth refers to a group of parasitic worms which consist of a number of phyla, many of 
which are unrelated genetically, but bear superficial similarities. The four main phyla are Annelida, 
Platyhelminths, Nematoda, and Acanthocehala. The majority of helminths which infect humans are 
from the two phyla Platyhelminth and Nematoda. 
Helminths are internal parasites, meaning that unlike external parasites such as fleas and lice, they live 
inside the host, generally inside the digestive tract where they can receive nutrients from food 
consumed by the host as it passes through the gut. This nutrient acquisition occurs in competition with 
nutrient uptake by the host’s gut and so can lead to malnutrition as well as diseases in the host. 
Not all helminths remain confined to the intestinal tract. In some instances larvae may penetrate the 
mucosa of the small intestine and invade the blood stream, and so migrate to other parts of the body. 
Some species may also enter the host through the skin, most commonly on the feet and ankles, and 
from there can be transported around the body. While the majority of helminth infections occur in less 
developed countries, particularly in areas of poor sanitation, and infection rates in Europe have been in 
decline and are minimal compared to decades or centuries ago, they are often soil transmitted and so 
fall well within the scope of this report. For this reason, a more in depth discussion is given for each 
group below. 
 
2.4.1 Ascariasis 
The causative agent of ascariasis is Ascaris lumbricoides which is the largest intestinal nematode 
(nematodes are also known as roundworms) and is the most common form of human helminth 
infection worldwide. Along with hookworms and whipworms, Ascaris make up a group known as soil-
transmitted helminths.  
Ascariasis is most common in tropical and sub-tropical areas and is generally associated with poor 
sanitation. A. lumbricoides are capable of reaching more than 30 cm in length, which is more than two 
orders of magnitude greater than most nematodes which are found in the soil. This disparity in size is 
due to the relatively rich conditions with regard to nutrient availability, as well as lack of predation 
which occurs in the human intestine when compared to the soil environment. 
The life cycle of Ascaris involves eggs from an infected individual being excreted along with faeces 
which may contaminate the soil if a person defecates outside, of if the faeces of an infected individual 
are used as a fertilizer. Ascariasis is then spread when a non-infected individual ingests eggs from the 
soil, either through fingers which have come into contact with contaminated soil being put into the 
mouth, or by easting fruit or vegetables which have come into contact with the infected soil which 
have not been adequately washed, cooked or peeled. 
Ascariasis may present with no symptoms in some individuals. However, other individuals may 
develop a compromised nutritional status, abdominal pains, low grade fever, and in the case of more 
heavy infection, intestinal blockage or rectal prolapse. In some instances, larvae may penetrate the wall 
of the intestine and enter the blood stream where they can migrate to other parts of the body, most 
commonly the lungs, where they cause a form of the diseases known as ascaris pneumonitis. In the 
lung, the nematodes can cause inflammation and haemorrhaging and can increase the propensity for 
the individual to contract bacterial lung infections. 
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The ECDC does not track ascariasis infection within the EU27. The WHO has 8 deaths registered 
under the ICD 10 codes as having occurred within the EU between 1994 and 2006. 
 
2.4.2 Echinococcosis 
Echinococcosis is caused by parasitic platyhelminthes from the genus Echinococcus. Different species 
of this genus are associated with different forms of the disease. The life cycle of these parasitic worms 
involve several different hosts, each of which is associated with a different stage in the life cycle of the 
worm and transmission between which may involve the soil. 
Carnivores are the definitive hosts of the worm, with foxes being the predominant definitive hosts of 
the species E. multicularis within Europe (rodents generally act as intermediate hosts). Infection with 
larvae of this species causes alveolar echinococcosis which resembles a slow growing malignant 
tumour. It originates in the liver and may spread to other organs through metastases, and is lethal 
without treatment (Vuitton 2010). 
Human infection occurs through contact with egg-containing faeces, soil or plants and occurs through 
hand to mouth transfer (Eckert and Deplazes 2004). The eggs have been found to be easily killed as 
high temperatures but highly resistant to cold, as well as all known antiseptics (Scott et al. 2011) and 
soil moisture has been found to play a key role in the survival times of eggs within soil (Hansen et al. 
2003). 
The disease presents with abdominal pain in the upper right quadrant in approximately 30% of cases 
which may last for several years before lesions develop. Jaundice develops over time and is present in 
20% of cases with inflation of the liver occurring in 16% of cases (Vuitton 2010). Other symptoms 
may include bone pain, skin tumours, shortness of breath, fever and possible gallstone like symptoms. 
The ECDC registered between 966 cases (2007) and 789 cases (2009), although data is unavailable for 
infection rates in Denmark and Italy. The WHO registered 597 mortalities as attributed to 
echinococcosis of various forms (e.g. Echinococcus granulosus infection of lung or liver or 
echinococcosis, unspecified, of liver) under the ICD10 codes in the EU 27 between 1997 and 2008. 
Information concerning mean annual infection rates per country can be seen in Fig 16. 
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Fig 16: Mean annual infection rates of echinococcosis in the EU27 by member state per 100,000 
people for 2006 - 2009. Bars show standard error. Data not available for Denmark, Italy or The 
Netherlands. 
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2.4.3 Hookworm 
Two species of parasitic nematodes which infect humans are known as hookworms. These are 
Ancylostoma duodenale and Necator americanus. Both species are found throughout the tropics and 
sub tropics, with over lapping distributions, although A. duodenale is most common in North Africa, 
India and the Middle East, and formerly in southern Europe. N. americanus on the other hand, is most 
common in the Americas, Sub-Saharan Africa, Indonesia, China and Southeast Asia. Both species of 
hookworm combined are estimated to infect more than 740 million people globally (Tam et al. 2011). 
Hookworms are considerably smaller than Ascaris lumbricoides which is also a species of nematode 
(Section 2.4.1). This means that the risk of intestinal obstruction which may occur with A. 
lumbricoides is much less with hookworms. The most significant risk of hookworm infection is 
anaemia due to loss of iron from the gut, the uptake of which is competitive between the hookworms 
and their host. 
Humans are the only known reservoir for hookworms. Infection occurs through contact with soil 
which has been contaminated with faeces. Larvae are able to penetrate the skin, usually though the feet 
which may cause a stinging or burning sensation. The larvae then migrate to the gut of their host. 
Infection may also occur through ingestion of eggs or larvae, through the hand to mouth route after 
touching infected soil or water.  
Infection rates can be as high as 80% in lesser developed countries in the most tropics, but is only 10-
20% in drier climates, probably owing to the relatively poor survivability of the eggs and larvae in dry 
soils. Particle size distribution of soils and organic matter content have also been shown to play an 
important role in the survival of hookworm larvae in soils (Mabaso et al. 2004) possibly due to their 
impact on soil water retention. 
The ECDC does not track infection by hookworms within the EU27, although cases of infection are 
likely to be minimal if any. The WHO has 1 death registered as attributed to hookworm disease under 
the ICD 10 codes which occurred in France in 2003. However, it seems highly likely that the diseases 
itself was contracted outside of France. 
 
2.4.4 Strongyloidiasis 
The causative agents of strongyloidiasis are two species of parasitic nematode from the genus 
Strongyloides (also known as threadworms), S. stercoralis which is the most common of the two 
which cause infection in humans, and S. fulleborni which is mainly found in Papua New Guinea and 
some areas of Africa. Many hosts infected with Strongyloides remain asymptomatic although the 
disease may cause life threatening infections in immuno-compromised hosts with a 60-85% mortality 
rate (Asdomongkol et al. 2006).  
Infection with Strongyloides may be as high as 40% in some areas where soil is moist and sanitation is 
poor. 
Strongyloides can survive for extended periods in the soil owing to the fact that it has two types of life 
cycles. One of these is a free-living life cycle, meaning the organisms can survive for generations and 
so persist indefinitely in soil. However, infection may be transmitted to humans when a person comes 
into contact with soil containing Strongyloides in their larval “filariform” stage. These larvae can enter 
a host through the skin, where they enter the circulatory system via the lymphatic system and are 
carried to the lungs. Once in the lungs they migrate upwards to the throat where they are then 
swallowed and enter the digestive tract. The infected host may be asymptomatic for this entire time, 
with the exception of hives at the point of entry which may be mistaken for insect bites. Once in the 
lower tract of the digestive system, Strongyloides may be excreted in faeces. The time taken from the 
initial penetration of the skin, through migration to the lungs and back down into the intestine to be 
passed out in faeces once more is in the range of 17-28 days. Strongyloides are the only helminth to 
secrete larvae and not eggs in faeces (Chandrasekar et al. 2011). 
The ECDC does not track infection by hookworms within the EU27, although cases of infection, if 
any, are likely to be minimal. The WHO has 7 deaths registered as attributed to strongyloidiasis within 
the EU27 between 1998 and 2006. 
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2.4.5 Trichuriasis 
The causative agent of trichuriasis is Trichuris trichiura, also known as whipworm which is a very 
common intestinal parasite with approximately one quarter of the world’s population being through to 
carry the nematode. The name “whipworm” is due to their shape as they have a wider posterior end 
with a longer, thinner anterior end which means that they can look like a whip with a handle. 
Infection occurs through ingestion of eggs from soil in areas of poor sanitation. Eggs which are 
deposited onto the soil become embryonated after 10 – 14 days in the soil which is the infective stage 
of their life cycle (Donkor and Lundberg 2011). Once ingested, the larvae develop within the small 
intestine before passing into the cecum where they penetrate the mucosa before going on to complete 
their development into adult worms in the large intestine. Adult worms bury their thin, threadlike 
anterior parts into the intestinal mucosa and feed on tissue secretions (not including blood). 
Approximately three months is needed for eggs to develop into mature worms which may live for 
between 1 and 5 years. Adult females can lay eggs for up to 5 years and may shed up to 20,000 eggs 
per day which can survive for up to 14 days in soil (Acha and Szyfres 2003).  
 T. trichiura is often found in association with other helminth infections which inhabit similar 
conditions such as A. lumbricoides. 
Infections usually present asymptomatically apart from in individuals infected with numerous worms. 
Symptoms, where present, include vague abdominal discomfort, stunted growth, nocturnal lose stools, 
possible dysentery, and in some case rectal prolapse. 
Whipworm infection is estimated to affect nearly 25% of the world’s population, with infection being 
more common in less developed countries. However, 2.2 million individuals are thought to be infected 
in the rural South East area of the United States (Donkor and Lundberg 2011). 
The ECDC does not register data on infection rates of trichuriasis within the EU27. The WHO has 5 
deaths registered as attributed to trichuriasis in the EU27, all of which occurred in Germany in 1998. 
 
 
2.4.6 Trichinellosis 
Trichinellosis is also known as trichinosis, the causative agents of which are nematodes from the genus 
Trichinella, most commonly T. spiralis. Trichinellosis is a zoonotic illness which is spread through 
pigs via various pork products if not cooked sufficiently. Trichinella are not usually transmitted 
through the soil; rather infection is spread through encysted worms in infected muscle tissue is eaten 
by carnivores, mainly pigs, rats or humans. However, a theoretical mechanism in which encysted 
worms are excreted into the soil in faeces and then ingested by individuals who may come into contact 
with the soil may be possible, in a similar way to the other helminths discussed in this report. 
However, data on the possibility of this mechanism or the survivability of Trichinella within the soil is 
not currently available in the literature. 
The disease is of some clinical importance within the EU27. Between 688 and 787 cases of 
trichinellosis are registered with the ECDC as occurring within the EU 27 between 2006 and 2009 
(except for Denmark for which no data is available). The majority of cases within the EU 27 were in 
Romania (75% of cases in 2008) or Bulgaria (54% of cases in 2009). The WHO has 14 deaths 
registered as attributed to trichinellosis in the EU27 between 1996 and 2005. 
 
2.4.7 Other Helminth infections 
Schistosomiasis, caused by platyhelminthes of the genus Schistosoma, and enterobiasis caused by 
Enterobius vermicularis (also known as pinworms) are not discussed within this report. This is 
because while there is a theoretical possibility of them being transmitted by the soil the means of 
infection is overwhelmingly aquatic in the case of Schistosomiasis or from person to person contact in 
the case of enterobiasis that they do not fall within the scope of this report. 
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2.5 Prions 
Prion diseases are caused by specific, mis-folded proteins which can function as infective agents. They 
propagate by transmitting the mis-folded state and thereby converting properly folded proteins to the 
diseases associated prion form. Of the five main prion diseases which have been identified to occur in 
humans: Creutzfeldt-Jakob Disease (CJD); Variant Creutzfeldt-Jakob Disease (vCJD); Kuru; Fatal 
familial insomnia; Gerstmann-Straussler-Scheinker Syndrome, it seems most probable that only CJD 
and vCJD are possible to be transmitted through the soil. This is because Fatal familial insomnia; 
Gerstmann-Straussler-Scheinker Syndrome both seem to require at least a genetic predisposition to the 
disease if the diseases is not hereditary, and Kuru is associated with cannibalism and so is not currently 
associated with transmission from the soil. For this reason on CJD and vCJD are discussed in this 
report although it should be noted that the soil as a route of transmission is currently hypothetical and 
further research is needed to confirm or reject this hypothesis. 
Prions have been shown to be spread orally, and to be able to cause disease in individuals who 
ingestion prions, in humans in the case of Kuru, and from the environment in the case of deer 
(Balchandran et al. 2010). As to whether humans can contract a prion disease straight from the 
environment (e.g. through the ingestion of prions from contaminated soil or dust) is not yet know. 
However, prions have been shown to survive for several years in the soil (Brown and Gajdusek 1991), 
and that binding of prions to montmorillonite, a common soil mineral, can increase the oral 
transmissibility of prion disease (Johnson et al. 2007). However, as the infectious dose of prions 
necessary to cause disease via oral transmission is unclear further research is necessary to elucidate 
whether this means of horizontal transmission of prion disease does, or may occur in humans. 
Some preliminary evidence suggests that control of the longevity of prions within soil may be possible, 
although difficult at large scales. Nachitaylo et al. (2010) demonstrated that some soil enzymes are 
capable of increasing the rate of degradation of prions within soil, but that proteolytic enzymes which 
are capable of degrading prions in the soil are inhibited by aprotinin and leupeptin, two organic 
compounds which are often produced and released into the environment by the soil microbiota. If a 
method of reducing the production of these compounds within the soil could be found it is possible 
that the longevity of prions within the soil may be reduced. 
 
3. Mapping of soil borne diseases 
Several efforts have been made to produce maps of diseases incidence to aid spatial analysis and so 
help identify underlying mechanisms of various diseases. The first attempt at mapping diseases at a 
global scale appears to have been made by Finke in 1792, although this manuscript appears to have 
been lost or destroyed (Barrett 2000). Further attempts were made throughout the 19th century and 
through the 20th Century (Abrahams 2006) and include both national (Howe 1963) and international 
(May 1952) attempts at the production of maps showing the incidence of diseases. 
 
In order to fully assess the possible impacts of factors such as climate, land management practices, the 
impact of livestock etc, a high resolution database logging the incidence of infection of a soil borne 
diseases, as identified in this report, would be highly advantageous for allowing the testing of 
hypotheses, for example by comparing the incidence of soil borne disease such as aspergillosis, the 
spread of which may be exacerbated by tillage of the soil causing spores to be released into the air. By 
comparing areas where conventional tillage is prevalent with other areas where min or conservation 
tillage are prevalent the testing of the hypothesis that conventional tillage leads to increased incidence 
of aspergillosis would be testable. Clearly this would need a high resolution database, pulling together 
information on infections as identified by hospitals on a local level, ideally from several if not all 
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member states of the EU27 in order for the interactions with different land management practices 
under different climatic conditions and at different latitudes to be tested. 
 
 
 
Fig 17. Total number of infections of soil borne human diseases for which data is available 
through TESSy for the EU27, summed over the years 2006-2009. It should be noted that not all 
member states have provided data on infection rates for each of the soil borne diseases discussed 
in this report. This greatly limits analysis as data sets are incomplete meaning that inevitably 
some countries are shown with underreported infection rates. 
 
In an ideal situation it would be possible to track the incidence of each of the soil borne human 
diseases discussed in this report at, at least the country level, annually, although a higher resolution of 
spatial data would be preferable. This would facilitate the monitoring of changes in disease incidence 
to possibly allow an investigation into the mechanisms behind such changes in disease incidence. 
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4. Discussion 
The fact that not all countries implemented the 10th revision of the ICD codes at the same time means 
that information concerning date rates is not the same for all periods of time, for each country within 
the EU for which data are available. For this reason, the span of time for which mortalities are reported 
for each disease are always given along with the time span over which they occurred, which varies 
from disease to disease. Amalgamation of the different ICD coded WHO databases, if possible, would 
overcome this weakness and allow more data to be included in analyses as well as historical data to 
allow the tracking of changes in incidence of soil borne diseases over longer time frames than the 10-
12 years which is currently possible. 
Comparison between the TESSy database on infection rates by country and the WHO mortality 
database can not currently be made with a sufficiently high level of confidence to allow the 
undertaking of statistical analyses, such as calculating the mortality rate as a function of the number of 
infections for each soil borne disease for which data is available. This is because differences exist in 
the methods by which data is collected. For example, as the WHO mortality database uses data 
obtained from death certificates only one cause of death is usually given. This means other underlying 
illness may have not been reported. Furthermore, those mortalities which have been attributed to a soil 
borne disease may have been contracted outside of the EU27 and the initial infection not logged. 
Therefore, it cannot be said with confidence that of the X number of individuals reported as having 
been infected with a soil borne diseases, as registered in TESSy, Y number of them died as a result of 
the disease as registered in the WHO mortality database. While this is not currently possible with the 
data sets available and used in the construction of this report, this is clearly an aim which would be 
worthwhile achieving to allow for the identification of diseases hot spots where mortality rates are 
higher which can then help guide resource allocation or prompt further research as to why survival 
rates after infection vary. 
The resolution of the information provided within the WHO mortality database is not always 
sufficiently high to allow effective analysis to be undertaken. For example, ICD A09 is listed as 
“Diarrhoea and gastroenteritis of presumed infectious origin”. As will become clear in the following 
discussion of symptoms attributed to each soil borne disease, there are many which may lead to death 
through this mechanism. This means that any analysis of diseases which may include this as a 
symptom may under-represent the mortality rate owing to the fact that the underlying disease 
responsible for these deaths cannot be identified. 
With data concerning infection rates, one further weakness in the data with regard to analyses which 
can be undertaken for this report is that the source of the infection is unknown. While all of the 
diseases discussed within this report are capable of being caught from or transmitted through the soil, 
other means of infection are also possible in many cases, such contaminated food or water or possibly 
even person to person transmission. 
Another problem with the data which is currently available is the lack of spatial resolution. There is 
currently no easy way to access data on infection rates across Europe at anything other than the 
country scale. This means that it is not possible to model as to whether various types of soil borne 
disease and more associated with agricultural regions, or other predominant land types/uses. 
 
4.1 Possible Factors affecting SBDs 
4.1.1 Land use, change and management 
Several of the diseases outlined and discussed in Section 2 are capable of transmission from the soil by 
become airborne, for example in dust (e.g. Q Fever, aspergillosis, tularemia, sporotrichosis). These 
diseases are therefore likely to be those most directly affected by land management practices and land 
use change. For example, any activity which is associated with increased wind erosion, on which there 
is abundant information in the primary research literature, seem likely to increase the incidence of 
these diseases in the surrounding area. Such activities could include land use change, for example by 
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ploughing grassland to make arable land, ploughing or tilling soil that is too dry, etc. These conditions 
may also increasingly occur under climate change, as that can lead to enhanced incidence of drought 
periods, besides periods with heavy rainfall. These conditions can be enhanced by more intense soil 
use e.g. when converting most primary production into biofuels, which reduces soil organic matter 
status and therefore erosion susceptibility Reduced soil tillage could be part of a solution, however, no-
till systems are usually associated with increased soil moisture and increased temperatures as well as 
increased crop residue, which might enhance the incidence of crop diseases, especially in short rotation 
cropping systems. The effects that these conditions will have on the abundance of the soil borne 
diseases identified by this report are not always clear, although the majority of the organisms discussed 
survive for longer periods of time in moist soil compared to dry soil. 
4.1.2 Use of pesticides and herbicides 
Some anecdotal evidence suggests that herbicides, particularly glyphosate, can reduce the abundance 
of neutral or beneficial soil organisms and so remove the biocontrol mechanisms which may help 
repress diseases casing organisms within the soil through factors such as competition for resources 
(Smith 2011). For example a 500% increase in Fusarium sp., a fungus, was noted in the roots of 
Roundup Ready soybean (Smith 2011). However, it should be noted that the information presented in 
this report is only anecdotal and no studies on this currently appear in the primary literature.  
Toxins produced by Fusarium sp. are suspected of being able to cause disease in humans (European 
Commission 1999). For example, the soil-borne plant pathogen Fusarium culmorum can cause marram 
grass (Ammophila arenaria) planter’s disease, particularly when the plant material had been stored 
under conditions favourable for fungal multiplication. The disease is not deadly, but can cause severe 
inconvenience to the planters Snijders et al 1996). There may be many more such examples with non-
lethal consequences, but severe inconveniency with associated socio-economic costs, and is an area 
requiring further research to investigate.  
In the case of Roundup Ready soybean, research is necessary to investigate firstly, whether glyphosate 
does lead to increases in diseases causing organisms in crop roots, and secondly whether toxins 
produced by these organisms, if they do exist at increased abundance, can be transferred to humans in 
sufficient concentrations to cause disease. The consequences of Genetically Modified Organisms 
(GMOs) especially in relation to modified crops may also need to be evaluated from the perspective of 
their influence on soil borne human diseases. 
4.1.3 Use of antibiotics  
Antibiotics are often used in livestock, both prophylactically and to cure diseases. They have been 
shown repeatedly to be able to survive passing through the animals and for 30-90% of the antibiotic to 
be excreted via urine or faeces as intact bioactive substances (USCDC 2011). Once released into the 
environment, the fate of the antibiotic varies depending on the type of antibiotic, its chemical structure 
etc. but has been shown to be capable of leading to increased resistance to antibiotics within soil 
microbial communities (Heuer et al. 2010).  
A full review is available on the movement of veterinary antibiotics in soils which can be highly 
variable depending on their molecular structure and atomic composition (Tolls 2001). Individual 
studies have investigated ways to restrict the mobility and control the fate of veterinary antibiotics in 
the environment. Heuer et al (2010) found that agroforestry and grass buffer systems have the potential 
to mitigate the spread of veterinary antibiotics from agricultural systems, and that root exudates, by 
enhancing microbial growth and potential degradation of the antibiotics through provision of an 
additional carbon source, may reduce the longevity of antibiotics introduced into the environment. 
However, as shifts in microbial community characteristics may occur depending on which species are 
sensitive to antibiotics and so are suppressed; predictions of the likely effects of antibiotics on the soil 
community are problematic. However, the fact that antibiotics can affect soil microbial communities 
and enzyme activities (Liu et al 2009) shows that further to increasing the possibility of antibiotic 
resistance developing and spreading, effects on soil fertility may also occur. 
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From the viewpoint of soil borne diseases of humans, when such veterinary antibiotics enter the 
environment they can be expected to place an evolutionary pressure on the communities with which 
they come into contact. In the soil, these communities are generally microbial and it can be expected 
that the evolutionary pressure placed via antibiotics on soil microbial communities is towards an 
increase in resistance to that antibiotic.  
Once antibiotic resistance has developed within a community, horizontal gene transfer which occurs 
frequently between bacterial species in the environment means that the resistance can spread and while 
it may not initially develop in an organism which is capable of causing disease in humans, it may be 
passed to such organisms (Allen et al 2010). This has been shown to have occurred with regard to 
tetracycline resistance which was found to develop in an aquaculture environment but which was then 
passed on to a human pathogenic bacteria (Rhodes et al. 2000). It seems likely therefore that the same 
has happened, or will happen within the soil environment leading to antibiotic resistance in other 
human pathogenic bacteria. Steps should be urgently taken to investigate how common such 
occurrences are and which steps can be taken to minimise the development of antibiotic resistance 
through such mechanisms. 
 
4.1.4 Climate change 
Prediction of the effects of climate change on the distribution of diseases causing organisms is 
problematic owing to uncertainties regarding the effects of climate change on climatic conditions at the 
local scale. However, it is notable that many soil borne diseases have relatively limited distributions 
across the world, with the majority of cases being restricted to the tropics or sub-tropics in some 
instances (e.g. Isoporiasis, Ascariasis, hookworms), or highly localised as for the fungus Coccidiodes 
immitis which is endemic to the San Joaquin valley region of California. Changes in weather patterns 
will lead to changes in their associated ecoregions and in instances where these changes favour soil 
borne pathogens or parasites of humans these diseases are likely to spread. 
Further to this, changes in weather patterns may affect diseases incidence in areas where diseases 
causing organisms are endemic. For example, increased rainfall leads to higher soil moisture levels 
which have been shown to enhance the longevity of STPs (Welshimer 1960; Chandler and Carven 
1980; Chao et al 1988). Conversely, drier soils can lead to increased wind erosion increasing the 
chances of inhaling soil particles from the air which be contaminated with disease causing organisms 
as well as of inhaling spores of infectious organisms. 
One large scale effect of climate change for which some evidence already exists is the apparent 
“migration towards the poles” of organisms where by the species range of several groups of organisms 
have been found to be spreading towards the poles. This has raised concern with the possible spread of 
malaria to previously malaria free areas owing to the migration towards the poles of malaria carrying 
mosquito species (e.g. Martens et al. 1999). The majority of soil transmitted helminth diseases occur in 
the tropics and sub-tropics and this range may well increase as a result of global warming. A further 
example is mycetoma, a fungal disease which is currently most common between latitudes of 15°S and 
30°N; this may change with climate change. 
Investigations as to which mechanisms are responsible for the limited species range of some soil borne 
diseases causing organism, which are likely to be a combination of climatic effects and soil physical, 
chemical and biological properties, may aid in predicting the likely effects of climate change on the 
species range of diseases causing organisms. Current information available in the literature suggests 
that changes in weather patterns which lead to moister soils may mean SBDs can survive for longer in 
new places, whereas changes in weather patterns which lead to drier soils may mean more incidences 
of SBDs which can be inhaled. 
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5. Recommendations 
This report is only a first step towards a thorough investigation of this relatively understudied area and 
only contains a relatively limited analysis of the data that is available on this matter. The logical next 
step following this report would be to put together an expert working group covering aspects such as 
epidemiology, medicine, statistics, soil biology, database management and GIS, and economics. This 
cross-disciplinary working group would allow the production of a comprehensive reference report to 
the European Commission containing analysis of factors such as the socio-economic impacts of soil 
borne diseases within the EU27. Furthermore a cross member-state analysis of diseases incidence 
versus mortality would allow the identification of member states with the highest survival rates for soil 
borne diseases and may help provide insights into treatment efficacy etc.  
Such a group would allow the identification of questions which may already be answerable with the 
current data sets and to present such answers in the reference report. For example, an economical 
analysis of the cost of soil borne diseases to the European economy may be able to be undertaken with 
the information available on incidence of diseases within the EU27, accounting for both working days 
missed and the cost of treating infections. This exercise would also help quantify the socioeconomic 
effects of soil borne diseases. A sensitivity analysis of the data currently available would also provide 
a measure of the confidence at which any result obtained from the current data can be accepted. 
Data currently available with the ECDC are incomplete with not all member states providing figures 
on infection rates for all diseases for each year. This greatly limits the analyses that can be done and so 
inhibits investigation in to such factors as whether factors such as climate, latitude, land use etc. 
currently have any effect on disease incidence and whether such relationships are changing over time, 
in response to land use or climate change for example. 
Inclusion of colleagues from the ECDC and WHO in the working group would allow monitoring and 
discussion of data acquisition techniques and possible synergising of information available in data 
bases. This will increase the confidence with which comparisons of infection rates versus mortality 
rates for each disease can be made to give an indirect measure of survival rates. Analysis of differences 
between survival rates in member states may allow increased understanding of the most efficient ways 
to treat soil borne diseases. 
An expert working group would allow the identification of soil borne diseases which have the potential to cause 
a similar impact with regard to health and socio-economic factors as the EHEC strain 0104:H4 which caused 
the outbreak in Europe in 2011. These should be considered from the viewpoint of current changes in 
land/soil use and climate change and steps identified in a range of scenarios to help contain any such outbreak 
and to minimise the socio-economic and health impacts of such outbreaks. 
Georeferenced information at a high spatial resolution, ideally individual hospitals where diagnosis 
occurs, would allow the mapping of areas at increased risk of various soil borne diseases. Furthermore, 
it would then be possible to combine this information with that available from Corine Land Cover to 
investigate which land use types are most closely correlated with disease incidence as well as 
investigating the effects of land use change over time. 
While this is not currently possible with the data sets available and used in the construction of this 
report, this is clearly an aim which would be worthwhile achieving to allow for the identification of 
diseases hot spots where infection rates are higher, as well as identification of areas where human 
survival rates after infection may be lower. This can then help guide resource allocation or prompt 
further research as to why survival rates after infection vary. 
Discussion of the utility of sub-groupings of soil borne diseases further to the initial step made in this 
report could be undertaken from an inter-disciplinary point of view. For example, with the current 
groupings of ESPs and STP will allow some further investigation of the data available allowing for the 
fact that ESPs can be said with confidence to have been obtained from the soil whereas STPs cannot. 
This is important information for interpreting the data and any analyses. However, it is possible that 
from a socio-economic viewpoint a different division of the diseases may be useful, for example into 
occupational versus non-occupational. A multi-disciplinary team is necessary to have the required 
expertise to allow assessment of soil borne diseases from a range of viewpoints. 
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Finally the working group would be able to identify and priorities areas of our understanding soil 
borne diseases which are currently lacking and require further (experimental) investigation and so 
would aid in resource funding allocation. For example, investigations as to which mechanisms are 
responsible for the limited species range of some soil borne diseases causing organism, which are 
likely to be a combination of climatic effects and soil physical, chemical and biological properties, 
may aid in predicting the likely effects of climate change on the species range of diseases causing 
organisms. 
 
 
6. Conclusions 
In conclusion, this report is now able to answer the questions posed in Section 1.1. 
 
1. Which diseases are, or can be soil borne?  
A range of diseases have been identified in Table 1 showing that soil borne diseases can be caused by 
a wide range of organisms coming from disparate taxonomic groups which vary greatly in their 
virulence and prognoses. Soil borne pathogens and parasites can be split into two groups; those that 
reside in the soil as true soil organisms which can potentially cause diseases in humans, the euedaphic 
pathogenic organisms (EPOs); and soil transmitted pathogens (STPs) which are capable of surviving 
for extended periods in soil and so can cause infection even when there are no other infectious humans 
in the vicinity. 
 
2. Is there anything that we can do with regard to land management practices or other precautions that 
we can take which will help control the incidence of soil borne diseases?  
Some soil borne diseases have been shown to have higher incidence in people of some occupations, 
such as farmers, as well as to be affected by climatic, environmental and anthropogenic factors. Steps 
should be taken to identify which factors have the largest effect on disease incidence for each disease 
and so allow for measures to be taken or policy to be written to minimise the destructive effects and 
socioeconomic costs of soil borne diseases. 
 
3. Are there any human activities that enhance the risk of soil borne diseases? 
Evidence suggests that human activities which increase soil degradation processes can enhance soil 
borne disease incidence. For example, soil degradation or poor land management leading to increased 
wind erosion can lead to concurrent increases in some soil borne diseases owing to the increased 
abundance of fungal and bacterial spores in the air. Steps taken to reduce soil degradation processes 
and are likely to have concurrent benefits in some areas with a reduction in incidence of soil borne 
diseases. Other factors, like intensified carbon extraction from production systems for biofuel 
production, can be predicted to influence soil borne disease incidence, for example because lowered 
soil organic matter may enhance soil susceptibility to drying out and eroding, thereby spreading soil 
borne diseases. This needs further study.  
 
Finally, a key recommendation of this report is the formation of an expert working group on soil borne 
diseases. This would allow working towards identifying practices in land management practices which 
minimise the impacts of soil borne diseases, both in terms of human health and socio-economics 
factors. A concerted effort by an inter-disciplinary team would allow the identification of future risks 
of outbreaks or organisms such as EHEC strain 0104:H4 which caused the outbreak in Europe in 2011 
and which proactive steps can be taken to minimise the chances of an outbreak and to ensure the 
impacts are minimal should one occur. Furthermore, the construction of an integrated database made 
available to the expert working group and pooling information on mortalities from across WHO ICD 
codes, combined with information on soil borne disease infection rates available from the ECDC 
would allow monitoring of treatment efficacy in different member states, highlight areas where 
diseases are of particular risk and how these risks are changing over time. 
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